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ABSTRACT
BACKGROUND: Endothelial cells (ECs) line the blood vessel lumen and respond
to fluid shear stress. ECs are also responsible for initiating the formation of new
blood vessels. These new vessels can form either by sprouting angiogenesis or
intussusceptive, or splitting, angiogenesis. The latter is poorly understood but
recent evidence suggests that intussusception occurs in early vessels with ultralow blood flow. However, the biomechanical and biochemical mechanisms of
intussusceptive angiogenesis remain largely unknown and in vitro models do not
exist.
The purpose of this thesis was to develop a three-dimensional EC
culture model capable of forming transluminal pillars, a key step in
angiogenesis, and to utilize this model to identify regulators of pillar
formation.
METHODS: I developed a novel 3D microvessel model using microfluidic
channels of dimensions 100 µm x 100 µm x 1 cm (h, w, l). The channels were
circumferentially lined with a confluent monolayer of human umbilical vein
endothelial cells (HUVECs). Programmable syringe pumps were used to expose
cells to range of shear stresses from physiological (10 dyn/cm2) to ultra-low (0.02
dyn/cm2).

Cells

were

immunostained

for

VE-Cadherin,

ARL13b,

and

phosphorylated VEGFR2 (pVEGFR2). A similar microfluidic model in channels of
dimensions 300 µm x 1000 µm x 1 cm (h, w, l) was used to co-culture RFP- and
GFP-expressing HUVECs differentially treated with control or VEGFR2 siRNA
and subjected to ultra-low shear stress to directly test the role of VEGFR2 in
pillar formation.
RESULTS: Endothelial cells exposed to ultra-low shear stress showed marked
changes in morphology compared to cells exposed to physiological shear stress,
including a decrease in elongation, more random orientation, and a shift in Fii

actin from stress fibres to cortical actin. Importantly, transluminal pillars were
identified at the channel shoulders and pillar abundance was 8.8-fold higher
under ultra-low shear stress. Furthermore, ARL13b expression was 1.9-fold
higher in HUVECs exposed to ultra-low shear stress, suggesting an increase in
primary cilia under ultra-low shear. Interestingly, ARL13b was also localized with
transluminal pillars. Expression of pVEGFR2 decreased by 22% in cells
subjected to ultra-low shear stress and was identified in the mid-region of pillars
and lateralized to the upstream surface. A co-culture of RFP- and GFP-HUVECs
differentially transfected with control siRNA or VEGFR2 siRNA demonstrated a
12.5-fold increase in pillar frequency in cells with reduced VEGFR2 content
under ultra-low shear stress.
CONCLUSIONS: I established a 3D microfluidic culture model of endothelial cells
that successfully yields transluminal endothelial pillars. Pillar formation was
stimulated by ultra-low shear stress and further enhanced by VEGFR2
downregulation. Immunostaining for ARL13b and pVEGFR2 suggested shearseeking behaviour may underlie pillar formation. This interplay between ultra-low
flow and shear-seeking behaviour constitutes new insights into intussusceptive
angiogenesis.
Keywords: endothelial cell, microfluidics, transluminal pillar, intussusceptive
angiogenesis, primary cilia, VEGFR2, peripheral arterial disease, ischemic injury,
shear stress
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SUMMARY FOR LAY AUDIENCE
Peripheral arterial disease (PAD) is a disorder common among older
individuals and diabetics wherein the arteries that supply blood to the muscles in
the leg become blocked, starving the tissue of oxygen. New therapies for PAD
include attempting to promote the growth of new blood vessels to return blood
flow to these muscles. However, these therapies have seen little success in
patients.
In this thesis, I developed a 3D model of a blood vessel using microfluidics
to understand how new blood vessels form. I particularly investigated how a
single vessel can split into two. I discovered that endothelial cells that line blood
vessels can be made to take on a flow-seeking behaviour that motivates them to
stretch across the blood vessel channel. This happens when the blood flow in the
vessel is low.

The study revealed the critical first steps in blood vessel

duplication.
This knowledge could help in developing therapies that stimulate blood
vessel development to restore blood flow to damaged leg muscles in patients
with PAD.
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CHAPTER 1:
GENERAL INTRODUCTION
Peripheral arterial disease (PAD) is a devastating type of ischemic
disease that is caused by chronic arterial occlusion and leads to reduced oxygen
and nutrient levels in downstream tissue. This leads to damage or death of the
tissue and surrounding microvascular networks. Therapeutic strategies for PAD
beyond surgery and catheter interventions are limited. Recently, considerable
research has focused on therapeutic angiogenesis, i.e. stimulating new blood
vessel growth to reperfuse the ischemic tissue. However, these methods of
therapy have shown little clinical success, failing to produce long-term benefits
for patients (Inampudi et al., 2018).
Currently, the most studied mode of blood vessel formation is sprouting
angiogenesis. In this process, endothelial cells (ECs) lining the lumen of a vessel
migrate into the surrounding tissue, lumenize, and anastomose to form new
perfusable vessels from a pre-existing blood vessel (Carmeliet, 2000).
Accumulating evidence reveals that the stimulatory and regulatory mechanisms
of sprouting angiogenesis involve a wide variety of soluble biochemical factors,
and extracellular matrix and biophysical cues, e.g. shear stress, that directly or
indirectly impact EC biology. Nevertheless, angiogenesis can also occur via a
less understood approach called intussusceptive, or splitting, angiogenesis (IA).
During intussusceptive angiogenesis, ECs form a bridge called a transluminal
pillar across a lumen with blood flow and extend this bridge along the length of
the vessel (Djonov et al., 2000). This process effectively splits one large vessel
into two smaller daughter vessels, constituting a quick and efficient way of
vascular growth when compared to sprouting angiogenesis. However, little is
known about the biochemical and biomechanical regulation of this angiogenic
process.
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Recently, our research group has undertaken a detailed investigation of
angiogenesis in ischemic muscle of mice (Arpino et al., 2017a). In response to
femoral artery excision and subsequent infarction of lower limb muscle,
microvasculature in the skeletal muscle was obliterated and quickly regenerated
in a coordinated manner with myofiber reconstitution. We also observed that
intussusceptive angiogenesis was the predominant mode of angiogenesis for
blood vessel regeneration, as opposed to sprouting angiogenesis which could
only be identified occasionally (Arpino, 2017b). Notably, vessels undergoing
intussusception demonstrated a markedly low blood flow, with <2% of normal
shear compared to normal microvessels. Given the ability of ECs to sense and
respond to blood flow, this unique ultra-low flow could be responsible for
triggering intussusceptive angiogenesis. However, there is no ex vivo model to
study intussusceptive behaviour of ECs. This greatly limits the research progress
to understanding the biochemical and biophysical factors of intussusceptive
angiogenesis.
The broad goal of my thesis was to develop an in vitro culture model of
ECs that enables formation of an EC transluminal pillar, the early landmark of
intussusceptive angiogenesis. Addressing this entailed generating a 3D microscale vessel-like structure and delivery of ultra-low flow. I subsequently utilized
this model to study the role of endothelial mechanosensors and morphogenetic
behaviours of ECs in the induction of intussusceptive angiogenesis.
My specific objectives were:
1) To develop an in vitro model of early forming, primordial blood vessels
using 3D microfluidics and ultra-low flow.
2) To determine if transluminal endothelial pillars will form in the microfluidic
model.
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3) To determine the expression and localization of select shear stress
sensors in endothelial cells subjected to ultra-low flow and pillar-forming
conditions.
4) To determine the role of vascular endothelial growth factor receptor 2
(VEGFR2) in endothelial transluminal pillar formation, in vitro.
I hypothesize that endothelial cell transluminal pillar formation depends on
altered shear stresses. I further hypothesize that pillar formation will entail
changes in expression and/or activation of shear sensors, including VEGFR2.

1.1 Cardiovascular Disease
1.1.1 Ischemic Cardiovascular Disease
Cardiovascular disease is a debilitating class of disorders that dramatically
reduces patient quality of life and can quickly lead to death without, and
sometimes even despite, receiving the correct therapeutics. Within the large
category of cardiovascular diseases, ischemic cardiovascular disease presents
with one of the highest mortality rates. (Yusuf et al., 2001). This devastating
disease is caused by the narrowing or occlusion of arterial vessels, reducing the
flow of blood to downstream organs and tissues. Such ischemia and its
outcomes can be seen among coronary artery disease and peripheral arterial
disease.
1.1.2 Peripheral Arterial Disease
Peripheral arterial disease is a type of ischemic vascular disease affecting
the extremities, most frequently the legs. PAD is a widespread health problem,
with studies reporting 202 million people suffering from the disease globally, with
greater than 8.5 million people above the age of 40 in North America alone
(Benjamin et al., 2018).

As the disease progresses, atherosclerotic lesions

progress in the major arteries feeding these extremities, either partially blocking
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or completely occluding the vessel (Annex, 2013). This arterial stenosis leads to
a reduction in blood flow to downstream tissue, in turn reducing the amount of
oxygen and nutrients delivered to the tissue. This can then result in ischemic
injury and irrevocable tissue necrosis, if not addressed at an early stage.
Common clinical symptoms of PAD include limb muscle fatigue, numbness,
exercise-induced pain, and consequent reduction in limb function.
The most severe form of PAD manifests as critical limb ischemia (CLI),
occurring in 1.3% of patients with PAD (Benjamin et al., 2018). Patients with CLI
suffer a worsening of PAD symptoms, including persistent rest pain, non-healing
skin ulcers, gangrene, and even loss of toes or legs due to chronic, severe
ischemia and/or infection.
1.1.3 Therapeutics for Peripheral Arterial Disease Patients
Despite the extremely poor outcomes of CLI, therapies that result in full
recovery of the affected limb are limited. Currently, endovascular and open
surgical revascularization procedures are the primary methods of CLI treatment
(Kinlay, 2016). However, many CLI patients either undergo unsuccessful
revascularization procedures or are not eligible for such procedures (Uccioli et
al., 2018). In fact, a study performed by Chung et al. (2015) on a cohort of 8334
CLI patients found 46% of patients ultimately required major amputation. These
types of major amputation, such as above-ankle amputation, are associated with
greatly negative impacts on the quality of life of affected patients, as well as on
costs of healthcare. Therefore, there is an urgent need to develop therapies for
CLI that can effectively reduce the risk of amputation.
Therapeutic angiogenesis has recently been investigated as a means of
treating various stages of PAD, including CLI. These therapies propose that the
application of exogenous pro-angiogenic biochemical factors, such as vascular
endothelial growth factor-A (VEGF-A), hepatocyte growth factor (HGF), and
fibroblast growth factors (FGFs), can stimulate the growth of blood vessels in
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ischemic tissue, thereby restoring blood flow and supporting the repair of
chronically damaged skeletal muscle. However, despite promises derived from a
variety of preclinical animal models, therapeutic angiogenesis has been met with
limited success in clinical trials (Simons and Ware, 2003). Such clinical
disappointment stresses on the requirement of a deeper understanding of the
molecular and cellular mechanisms of blood vessel regeneration in ischemic
tissue. In this regard, our group has demonstrated that, in a mouse model of CLI,
ECs in ischemic skeletal muscle displayed a robust regenerative capacity to
reconstitute a perfusable microvascular network in a tightly coordinated manner
of skeletal muscle fiber reconstruction (Arpino et al., 2017a). Surprisingly, we
observed intussusceptive angiogenesis as the major mode of blood vessel
regrowth in ischemic muscle (Arpino, 2017b). The molecular cascades in ECs
undergoing intussusception remain poorly characterized, largely attributed to lack
of a proper in vitro cell model. In my thesis, I will present evidence for a first-inkind EC culture model that recapitulates the early phase of intussusceptive
angiogenesis.
1.2 Angiogenesis
1.2.1 Sprouting Angiogenesis
Sprouting angiogenesis is the most well-characterized form of new blood
vessel growth in embryonic development, tumorigenesis, and regeneration of
damaged adult tissue. This process is commonly triggered in tissue experiencing
a certain level of hypoxia, or low oxygen content (Carmeliet, 2000). Parenchymal
cells will begin to secrete a pro-angiogenic factor called vascular endothelial
growth factor A (VEGF-A). VEGF-A binds to its cognate receptors on the surface
of the EC membrane. The VEGF receptors are comprised of three family
members: VEGFR1, 2 and 3, with VEGFR2 considered the major signal mediator
to stimulate sprouting angiogenesis. VEGF-A-VEGFR2 binding causes the EC to
secrete proteolytic enzymes to break down the extracellular matrix (ECM)
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proteins and allow for this cell, now called the “tip cell”, to protrude into the
surrounding tissue toward the source of VEGF-A, along an established VEGF-A
gradient (Figure 1.1, Ribatti and Crivellato, 2012). Endothelial cells migrating into
the surrounding tissue will then lumenize to create a blood vessel capable of
receiving flow and successfully re-oxygenating the previously hypoxic tissue.
1.2.2 Intussusceptive Angiogenesis
Sprouting angiogenesis, while the most studied form of blood vessel
growth, is not the only process of angiogenesis. Another, much less understood
form of angiogenesis, is known as intussusceptive angiogenesis. During this
process, pre-existing capillaries will enlarge and ECs primed to begin the process
of angiogenesis will protrude into the lumen of the vessel rather than into the
surrounding tissue (Djonov et al., 2000). This cell will reach for another EC on the
opposite side of the vessel, fusing with this cell to form a bridge across a flowing
vessel lumen termed an endothelial transluminal pillar (Figure 1.2). Multiple
pillars then form down the length of this capillary, allowing fusion of neighbouring
pillars to eventually create a wall that splits one large vessel into two smaller
blood vessels.
The first studies to observe IA were in the developing rat lung
microvasculature in 1986, followed by in the chick chorioallantoic membrane
(CAM) in 1993. Caduff et al. (1986) identified small holes in the developing
alveolar microvasculature by studying its casting using scanning electron
microscopy, despite identifying no vessel sprouts to indicate sprouting
angiogenesis. These “holes” were later proven to be pillars by Patan et al.
(1993), who discovered the existence of transluminal EC bridges in a CAM
model. To date, intussusceptive angiogenesis has been primarily identified
during development of various tissues, including but not limited to the
mammalian retina, ovary, kidney, as well as during tumour
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Figure 1.1 Sprouting Angiogenesis
Sprouting angiogenesis is the best understood method of blood vessel growth.
Central to this process is the secretion of VEGF-A by parenchymal cells that
binds to and phosphorylates VEGFR2 on the surface of an endothelial cell lining
a pre-existing vessel, now called a tip cell. This tip cell migrates into the
surrounding tissue towards the hypoxic tissue, along a gradient of VEGF-A, and
signals to its neighbouring stalk cells to proliferate and extend the length of the
sprout.
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Figure 1.2 Intussusceptive Angiogenesis
Intussusceptive angiogenesis is a poorly understood form of new blood vessel
development from pre-existing blood vessels. In this method, an endothelial cell
lining a pre-existing vessel will connect to ECs on the opposing side of the vessel
lumen, forming an endothelial-based bridge known as an EC transluminal pillar.
This pillar will extend down the long axis of the vessel, fusing with neighbouring
pillars, to split one large blood vessel into two smaller daughter vessels.
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vascularization (Taylor et al., 2010; Macchiarelli et al., 2006; Makanya et al.,
2005; Paku et al., 2011). Despite its identification in multiple human and animal
tissues,

the

biochemical

and

molecular

regulation

of

intussusceptive

angiogenesis, specifically the formation of the transluminal pillar, remains understudied and poorly understood.
1.2.3 Intussusceptive Angiogenesis in a Mouse Model of PAD
Recently, our research group has utilized a mouse model of PAD created
by the excision of the hindlimb femoral artery to study regenerative angiogenesis
in ischemic tissue, specifically skeletal muscle (Arpino et al., 2017a). Using this
model, we have discovered a high incidence of enlarged capillaries which
showed a high frequency of luminal EC protrusions akin to EC transluminal
pillars (Arpino, 2017b). These results suggest regenerative angiogenesis in the
ischemic hindlimb relies heavily on intussusceptive angiogenesis as opposed to
sprouting angiogenesis. Moreover, the velocity of red blood cells (RBCs) in these
primordial vessels was markedly slower than that seen in the microvascular
network of healthy skeletal muscle. Whereas physiologic shear stress
magnitudes range from 10 – 20 dynes/cm2, in these vessels shear stress was an
average of 0.08 dynes/cm2. Characterization of VEGFR2 activation by
immunostaining showed an overall decrease in phosphorylated VEGFR2
(pVEGFR2) within transluminal pillars. Moreover, the pVEGFR2 found within
pillars was localized to the midsection. These findings suggest a potentially vital
role for ultra-low flow as well as a reduction in VEGFR2 activity in the formation
of

transluminal

pillars

and

subsequent

progression

of

intussusceptive

angiogenesis.

1.3 Endothelial Cell Flow Sensing
Healthy ECs are well-known for their ability to respond to changes in blood
flow rate by sensing what is known as shear stress: the tangential force of the
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blood flowing across the surface of the cell. Molecules and complexes activated
both directly and indirectly by this force include, but are not limited to, receptor
tyrosine kinases (RTKs), G-protein coupled receptors (GPCRs), ion channels,
adhesion molecules, membrane microdomains, and transmembrane receptors
(Figure 1.3; Ando and Yamamoto, 2013). Under normal physiologic flow, these
molecules cause reorganization of the EC cytoskeleton, as well as cell-cell and
cell-ECM interactions, to elongate cells in the direction of flow, redistribute focal
adhesions via an increase in actin stress fibres, and suppress mitosis. Shear
stress sensors, therefore, represent an important group of signalling molecules
vital for vascular health and maintenance (Table 1.1).
1.3.1 Receptor Tyrosine Kinases
Receptor tyrosine kinases (RTKs) encompass a group of receptors located on
the plasma membrane of various cell types. These receptors are activated by
extracellular ligand-binding, which causes oligomerization of two or more
receptors on the plasma membrane (Hubbard and Miller, 2007). This then leads
to autophosphorylation of the tyrosine residues on the cytoplasmic domain. Sites
of autophosphorylation can act as recruitment sites for signalling proteins that will
activate a cascade of downstream signalling pathways. RTKs such as VEGFR2
and Tie-2 angiopoietin receptor are known to be important in shear stress
sensing in vascular ECs.
VEGFR2, as previously noted, is a well-studied RTK whose liganddependent activation by VEGF is a key activator in the process of blood vessel
growth known as sprouting angiogenesis. However, VEGFR2 can also be
activated in a ligand-independent manner in response to shear stress. This RTK
forms a mechanosensory complex with junctional proteins called platelet
endothelial cell adhesion molecule-1 (PECAM-1 or CD31) and vascular
endothelial cadherin (VE-Cadherin) located at the cell-cell junction (Baeyens et
al., 2016). The activation and signal transduction pathway of this complex has
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Figure 1.3 Endothelial Cell Mechanosensing
Endothelial cells are able to sense and respond to changes in blood flow via the
tangential force created by the flowing blood across the surface of the cell, called
shear stress. Molecules and complexes that are activated by shear stress, known
as mechanosensors, include ion channels, GPCRs, RTKs, adhesion molecules,
namely integrins, and membrane microdomains such as the glycocalyx and
caveolae. An important shear stress sensor complex in endothelial cells consists
of VEGFR2, PECAM-1, and VE-Cadherin, which is then linked to b-catenin.
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Table 1.1 Endothelial Cell Shear Stress Sensors

*References can be found in Section 1.3 (pages 12-24).
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been largely elucidated. Briefly, tension induced by shear stress causes the
association of PECAM-1 with vimentin, an intermediate filament protein found in
the cytoskeleton. This association then transfers the tension from the myosin
within the cytoskeleton to PECAM-1, triggering activation of a Src-family kinase
responsible for transphosphorylation of VEGFR2. VE-Cadherin plays the role of
an adaptor within this mechanosensory complex along with its binding partner bcatenin, associating with VEGFR2 on the plasma membrane to facilitate its
activation

(Conway

et

al.,

2013).

Activated

VEGFR2

will

then

bind

phophoinositide 3-kinase (PI(3)K) and trigger a downstream signalling cascade
involving protein kinase B (Akt) and endothelial nitric oxide synthase (eNOS; Jin
et al., 2003). Ultimately, this signalling cascade leads to production of nitric oxide
(NO), which modulates vascular tone, suppresses cell proliferation, and inhibits
nuclear factor kappa B (NF-kB), thereby decreasing EC expression of adhesion
molecules (Tousoulis et al., 2012).
Another RTK known to be responsible for shear stress sensing is the Tie-2
angiopoietin receptor. While less is known about the activation of the Tie2
receptor compared to VEGFR2, it is known that Tie-2 is autophosphorylated in a
ligand-dependent manner via binding of angiopoietin 1 (Ang1). Its activation is
more sustained than that of VEGFR2 and is also velocity-dependent, meaning
activation increases as shear stress increases (Lee and Koh, 2003).
Phosphorylation of Tie-2 activates a similar PI(3)K/Akt pathway to VEGFR2
phosphorylation and ultimately aids in EC survival and maintained cell integrity.
1.3.2 Receptor Serine/Threonine Kinases
Receptor serine/threonine kinases (RSTKs) are transmembrane receptors
that function in a similar manner to RTKs. RSTKs can be classified as either type
I receptors or type II receptors depending on their role in signal transduction
(Piek et al., 1999). Briefly, following binding of a ligand to its corresponding
RSTK, a heterodimer of type I and type II receptors will form on the plasma
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membrane. The proximity of these receptors will allow the type II RSTK to
phosphorylate specific serine and threonine residues located on the intracellular
domain of the type I RSTK, thereby activating this receptor and allowing
downstream signalling. A well-known pathway controlled by RSTK signalling is
the transforming growth factor-b (TGF-b) pathway.
Recently, the role of one RSTK called activin A receptor-like kinase 1
(Alk1) in shear stress sensing has been uncovered. Baeyens et al. (2016) have
hypothesized that shear stress causes endoglin, a membrane glycoprotein, to
associate with Alk1 on the plasma membrane, resulting in an increase in the
sensitivity of Alk1 to one of its ligands, bone morphogenic proteins 9 (BMP9).
Ligand binding results in phosphorylation of SMAD1, SMAD5, and SMAD8,
which will then translocate into the nucleus to act as a transcription factor
(Franco and Gerhardt, 2016). The activation of this Alk1/endoglin pathway has
proven to be important in regulating EC proliferation under flow. Importantly, Alk5
has been shown to be crucial for Alk1 activation by mediating its recruitment into
a TGF-b receptor complex, allowing for this shear stress-induced signalling
pathway to progress (Goumans et al., 2003).
1.3.3 G-Protein Coupled Receptors
G-protein coupled receptors (GPCRs) are seven-transmembrane domain
receptors located on the plasma membrane responsible for transmitting
extracellular signals into the cell using guanosine triphosphate (GTP), a common
source of energy (Wettschureck and Offermanns, 2005). Extracellular ligand
binding to a GPCR causes a conformational change in the protein that results in
coupling of the receptor to a heterotrimeric G protein composed of a-, b-, and gsubunits. This drives the exchange of guanosine diphosphate (GDP) to GTP on
the a-subunit, which then dissociates from the plasma membrane G protein
complex and goes on to modulate the activity of downstream signalling

18

molecules. While many GPCRs have been implicated in shear stress sensing,
few have been proven to be essential for mechanosensing (Scholz et al., 2016).
GPR68 is a class A rhodopsin-like GPCR that has recently been shown to
be activated in response to both laminar and disturbed flow (Xu et al., 2018).
Unlike other GPCRs studied, this receptor has been proven to be expressed on
the surface of ECs, and necessary for sensing flow. Due to its classification and
its coupled G-protein complex, it is suspected that activation of GPR68 causes
cleavage

of

phosphatidylinositol

4,5-bisphosphate

(PIP2)

into

inositol

triphosphate (IP3) and diacylglycerol (DAG), ultimately leading to the release of
Ca2+ from intracellular stores. This likely leads to the synthesis of NO, among
other effects, in order to regulate vascular tone.
1.3.4 Notch1
Notch1 is a single-pass transmembrane protein that has been suggested
to act as a shear stress sensor. This receptor plays an important role in sprouting
angiogenesis by regulating tip cell selection, among its other crucial roles (Ribatti
and Crivellato, 2012). However, it has also been shown to be activated
specifically by laminar shear stress in the adult vasculature (Mack et al., 2017). In
this case, Notch1 is responsible for maintaining junctional integrity, encouraging
EC elongation in the direction of flow, and suppressing cell proliferation, most
likely by regulating intracellular Ca2+ concentrations.
1.3.5 Ion Channels
Ion channels are membrane proteins that form pores within the plasma
membrane that allow the passage of specific charged ions through the
membrane into and out of the cell. Many of these channels are gated, requiring a
chemical signal or mechanical force to open and allow the passage of ions.
Channels such as Piezo1, P2X4, and transient receptor potential vanilloid 4
(TRPV4) have been shown to activate in response to shear stress, changing
mainly Ca2+ concentration within the cell.
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Piezo1 is a mechanically activated cation channel expressed on the
surface of ECs, as well as mature RBCs and neuronal stem cells. Recently,
Piezo1 has been studied in-depth in RBCs and has been shown to be activated
by shear stress (Cinar et al., 2015). This causes an influx of Ca2+ into the cells,
thereby causing a release of adenosine triphosphate (ATP) from the RBCs. ATP
can then bind to signalling molecules on the surface of vascular ECs, such as
GPCRs, to induce synthesis and release of NO. The exact mechanism of ATP
release from RBCs has not yet been elucidated. However, two pathways of
activation have been suggested: 1) the influx of Ca2+ activates pannexin-1
channels, triggering ATP release from pools associated with the RBC membrane,
or 2) this influx depolymerizes actin filaments, leading to activation of cystic
fibrosis transmembrane conductance regulator (CFTR), a membrane chloride
channel, and subsequent release of ATP (Cinar et al., 2015). The indirect effect
of RBC-expressed Piezo1 on EC shear stress sensing could elucidate to a more
direct role of EC shear stress sensing.
P2X4 is an ATP-gated ion channel highly expressed on the plasma
membrane of vascular ECs. Laminar shear stress causes the release of ATP
from ECs, which then binds to P2X4 to induce an influx of Ca2+ into the cell in a
force-dependent manner (Ando and Yamamoto, 2013). Studies have suggested
that this causes the ATP-induced expression of Krüppel-like factor 2 (KLF2),
Krüppel-like factor 4 (KLF4), and eNOS (Sathanoori et al., 2015). KLF2 and
KLF4 are well-understood to be upregulated in ECs due to laminar shear stress,
imparting an atheroprotective phenotype and activating eNOS to control vascular
tone. Therefore, the indirect activation of P2X4 due to shear stress is important
for vascular health and EC survival under flow.
TRPV4 is another ion channel recently shown to be activated by shear
stress. TRPV4 is a non-selective cation channel expressed in multiple different
tissues, including the brain, cardiovascular system, liver, lung, and kidneys,
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among others. In the vasculature, TRPV4 has been shown to regulate vascular
tone (Ando and Yamamoto, 2013). This channel is activated by osmotic,
chemical, and mechanical cues, notably shear stress. Shear stress causes an
influx of Ca2+ through TRPV4 activation and, interestingly, recruitment of
additional TRPV4 to the cell membrane, creating a potentiating response which
enhances TRPV4 responsiveness to this mechanical force.
1.3.6 Endothelial Cell Adhesion Molecules
Adhesion molecules encompass a wide range of molecules, most of which
are transmembrane proteins, that are responsible for facilitating interactions
between cells, and between cells and the ECM. These molecules can be divided
into five families: immunoglobulin-like adhesion molecules, integrins, cadherins,
selectins, and the CD44 family (Murray et al., 1999). Adhesion molecules play an
important role in translating the tension placed on the cell produced by shear
stress into a biochemical response within the cell.
As previously mentioned, PECAM-1 and VE-Cadherin are parts of a wellstudied, vital mechanosensory complex along with VEGFR2 found at the
junctional border between cells. Integrins, however, also represent a category of
adhesion molecules that have been widely implicated in the translation of shear
stress tension to the cell. b1 integrin plays an adhesion role by anchoring the cell
via actin filaments in the cytoplasm to the ECM on the basal surface. In this case,
unidirectional and bidirectional flow cause both an increase and clustering of b1
integrin, allowing for the development of focal adhesions that develop within the
cell as F-actin stress fibres (Ando and Yamamoto, 2013). This allows for
alignment in the direction of flow.
Recently, b1 integrin has also been found on the apical surface of ECs
and is hypothesized to act in a manner independent of b1 integrin located on the
basal surface to respond to only unidirectional flow (Xanthis et al., 2019). Shear
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stress tension placed on these apical pools of b1 integrin causes a change in its
conformation in order to translate the force into downstream signalling, including
the accumulation of Ca2+ via activation of Piezo1 and TRPV4. This, in turn,
enhances EC alignment with the direction of unidirectional flow specifically.
Another integrin considered to act as an important shear stress sensor is
avb3 integrin. Similar to b1 integrin, shear stress causes a conformational
change in avb3 integrin that increases its binding affinity to its corresponding
ECM component vitronectin (Shyy and Chien, 2002). This increased binding and
subsequent aggregation of avb3 integrin proteins causes the adaptor molecules
Shc and focal adhesion kinase (FAK) to associate with integrins on the
membrane and become tyrosine phosphorylated. Shc association then activates
the extracellular receptor kinase (ERK) pathway. Integrins including avb3 are
also thought to regulate RhoA activation, leading to actin stress fibre formation
under shear stress (Tzima et al., 2001).
1.3.7 Plasma Membrane Structures
The plasma membrane has many structures that are crucial to cell
signalling, cell adhesion, and cell trafficking. These structures include glycocalyx,
lipid rafts, caveolae, primary cilia, and others, alongside the previously discussed
ion channels and signalling receptors. Caveolae, primary cilia, and glycocalyx
specifically have been outlined in the literature as important for shear stress
sensing and the subsequent translation of this force into biochemical signals.
Caveolae are plasma membrane invaginations similar to lipid rafts in that
they are rich in cholesterol and sphingolipids compared to the rest of the plasma
membrane (Shaul and Anderson, 1998). Unlike lipid rafts, these structures are
also rich in a protein called calveolin-1. Their primary role in most cell types is the
organization and accumulation of various signalling molecules including
signalling receptors, ion channels, and intracellular membrane-associated
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signalling molecules. In ECs, caveolae have been implicated in shear stress
sensing by mediating the activation of the ERK pathway through the association
of calveolin-1 with upstream signalling molecules located on the plasma
membrane, such as integrins, G proteins, and GPCRs (Park et al., 2000).
Primary cilia are extracellular rod-like structures that protrude from the
plasma membrane of cells. These structures are composed of doublets of
microtubules connected to a microtubule organizing centre. Though the exact
mechanism of shear stress sensing via primary cilia is unknown, two methods of
mechanosensing have been hypothesized (Ando and Yamamoto, 2013). First,
shear stress could cause bending of the cilia that translates to the cell via
cytoskeletal deformation. Second, bending of the cilia due to shear stress causes
the activation of ion channels that leads to an influx of Ca2+–this results in NO
production and a change in vascular tone. The presence of primary cilia
regardless of activation method has been shown to cause an increase in KLF2
expression, a known marker of EC shear stress response.
The glycocalyx encompasses a carbohydrate-rich extracellular coating
that lines the vascular endothelium on the luminal surface. The glycocalyx layer
responds to shear stress in a similar fashion to integrins via conformational
change that is translated into an intracellular signal through the cytoskeleton
(Tarbell and Pahakis, 2006). This conformation change also translates into
biochemical signals indirectly by changing various concentration gradients and a
change in the regulation of ions, amino acids, and growth factors moving through
the membrane. Both of these methods of signal transduction result in increased
production of NO.

1.4 Tools for Studying Endothelial Cell Flow Response
Endothelial cells have a wide range of shear stress sensors that range
from adhesion molecules to transmembrane receptors, each of which activates
signalling pathways that lend information to the cell about the magnitude of the
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force, the direction of the flow, and the type of flow, whether pulsatile or laminar.
While the responses of ECs to physiologic flow rates have been studied
extensively, responses to ultra-low shear stress levels, such as the 0.08
dynes/cm2 shear stress magnitude characterized by our research group in our
ischemic

mouse

model,

remain

unknown.

Furthermore,

examining

the

relationship between this ultra-low shear stress and the high incidence of
transluminal pillar formation seen in this model could lead to a better
understanding of the process of intussusceptive angiogenesis and its role in
regenerating ischemic tissue.
The importance of EC mechanosensing in maintaining the health and
integrity of tissues and their corresponding vasculature throughout the body
cannot be underestimated. Therefore, the study of changes in EC behaviour
under high flow and high shear stress has been a major focus in vascular biology
using tools such as parallel plate flow systems and lab-on-a-chip devices (Coon
et al., 2015; Shih et al., 2019). However, experiments studying both smaller order
blood vessels and ultra-low flow rates are lacking. Moreover, the current
strategies for addressing EC flow are largely 2D, not 3D. Therefore, the shape
and configuration of these flow chambers do not closely mimic the physiology
seen in the vasculature in vivo. Critical information concerning EC morphology,
and 3D interactions and signalling remains elusive using current methods.
1.4.1 Microfluidics
Microfluidics is a recently emerging field that uses networks of channels
within the micrometer range to manipulate and control fluid flow. These devices
generally consist of an inlet leading into a single or branched channel, which then
leads to an outlet. The inlet and outlet allow for the attachment of tubing that will
directly connect a fluid source to the microfluidic channel. However, the design of
the channel itself is readily customizable, allowing for varying channel heights,
widths, and lengths that coordinate with specific study aims, as well as control of
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flow rate. One important use of microfluidic devices seen in the literature is as
cell culture systems, wherein the walls of these channels can be used as a
surface on which to grow a wide range of cell types (Mannino et al., 2018; Osaki
et al., 2018). Microfluidic systems could therefore allow for the development of a
3D cell culture system capable of mimicking the structure of the microvasculature
more closely, along with the study of lower flow rates than have been previously
tested. The overarching principle of my thesis is that microfluidic systems present
a unique, novel opportunity to study and characterize EC morphologic and
biochemical responses to ultra-low flow in 3D.
While the field of microfluidics and its subjects of study have diversified as
the field has expanded, the materials used largely remain consistent.
Microfluidics emerged and popularized in the 1970s with the use of silicon and
glass, mainly for the sake of convenience. However, silicone is opaque and
therefore not compatible with most microscopy techniques. Glass, while more
commonly used, required expensive and sometimes complicated techniques to
bond to silicone and create closed channels (Sackmann et al., 2014). These
problems were solved in the 1980s with the introduction of polydimethylsiloxane
(PDMS), a material used widely in current microfluidics research, and led to the
development of soft lithography, a common microfluidic device fabrication
technique. PDMS has many advantages, including: 1) its gas-permeability, 2)
malleability, 3) it is inexpensive to use and easy to work with, 4) PDMS can easily
bond with itself, as well as made to bond other materials such as glass using
surface treatments, and 5) its hydrophobic surface can be tuned to be more
hydrophilic to allow the attachment and growth of various cell types (Sackmann
et al., 2014). The transition into using PDMS as the main structural component of
microfluidic device fabrication has allowed the size, shape, arrangement, and use
of microfluidics to broaden significantly.
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As described above, the wide range of sizes, shapes, and arrangement of
channels in microfluidics has broadened immensely and remains one of the main
strengths of the field. Using PDMS and soft lithography in microfluidic fabrication
allows channels to become highly customizable and tuned to the nature of the
study. In EC studies specifically, many investigators focus on branched-channel
designs that somewhat mimic the structure of the vasculature (Myers et al., 2012;
Lee et al., 2018). However, as use of microfluidics has increased, more
complicated channel designs have been introduced, including those connected to
a reservoir or chamber, channels sprouting from the main channel, and more.
Even when single straight channels are used, the size of the channels vary
greatly from study to study. Many research groups focus mainly on the height of
the device, which can range from 30 µm – 500 µm depending on the type of cell
or vessel they intend to study (Esch et al., 2011; Bischel et al., 2013). However,
when working with such small heights, the width of the channels tend to be
relatively large, helping to offset any pressure that would be introduced by high
flow rates in such a small channel. For example, Sakurai et al. (2018) used a
microfluidic device 50 µm in height and 150 µm in width to create a vascularized
bleeding model. Studies using channels with an equal height and width below
150 µm, while physiologically closer to what is seen in vivo, are rarely seen–even
more so when using a single channel geometry.
Finally, microfluidics also allows fine-tuned control and variation of flow
rate and shear stress, which can be modified to fit the cell or organ type being
studied. Focusing on microfluidic studies concerning the vascular cell types, the
majority of studies focus on high flow rates seen in healthy vessels.
Microvascular studies mainly use shear stress levels around 10 dynes/cm2,
corresponding to the shear stress seen within capillaries (van der Meer et al.,
2010; Regmi et al., 2017). Studies that do look at the effects of low shear stress
do so in the context of atherosclerosis or wound healing. Moreover, many studies
consider low shear stress to be on the order of 2–4 dynes/cm2 (Khan and Sefton,
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2011). Therefore, while a high shear stress environment has been consistently
studied, the effects of low shear stress, and particularly ultra-low shear stress,
remain largely untouched by research groups.

1.5 Aims of the Thesis
The rationale for my thesis is that there is a lack of knowledge concerning
EC morphologic and biochemical responses to ultra-low flow rates, conditions
that exist in disease and regeneration. In addition, there is no existing in vitro
model for transluminal pillar formation, a phenomenon that can occur within ultralow flow.
To address this, the overarching goals of my research were: 1) to develop
an in vitro model of early forming, primordial blood vessels using 3D microfluidics
and ultra-low flow (Chapter 2); 2) to determine if transluminal endothelial pillars
will form in the microfluidic model (Chapter 2); 3) to determine the expression
and localization of select shear stress sensors in endothelial cells subjected to
ultra-low flow and pillar-forming conditions (Chapter 2); and 4) to determine the
role of VEGFR2 in endothelial transluminal pillar formation, in vitro (Chapter 3).
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CHAPTER 2:
A NOVEL 3D MICROVESSEL MODEL FOR THE STUDY
OF ENDOTHELIAL CELL TRANSLUMINAL PILLAR
FORMATION
2.1 Introduction
Critical limb ischemia (CLI) is the most severe form of peripheral arterial
disease (PAD) characterized by a marked and irreversible reduction in blood
supply to the affected lower limb. This reduction in blood supply leads to a
decrease in oxygen diffusion to the skeletal muscle within the leg causing pain in
the leg at rest and non-healing ulcers, and resulting in ischemic injury (Varu,
2010). There has been considerable interest in therapies for CLI that centre
around strategies to encourage new blood vessel formation in a process called
therapeutic angiogenesis in order to reperfuse the damaged skeletal muscle.
However, these methods have shown little clinical success in translating into long
term benefits for the patient (Inampudi et al., 2018). Therefore, there may be a
critical lack of knowledge surrounding blood vessel growth in an ischemic setting.
The growth of new blood vessels in an existing microvascular network is
best understood to occur via sprouting angiogenesis. In this process, endothelial
cells (ECs) lining the lumen of an existing blood vessel will be stimulated by
nearby low-oxygen conditions to migrate into the surrounding tissue. From there,
these cells will lumenize to allow blood flow within this new vessel, which will
then help with reperfusion of the previously hypoxic tissue (Carmeliet, 2000).
However, there is another form of blood vessel growth that is understudied called
intussusceptive angiogenesis. In this case, ECs lining the vessel will protrude
into the blood-perfused lumen to create a structure known as a transluminal pillar
(Djonov et al., 2000). Multiple EC pillars will then form along the length of the
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vessel and fuse with neighbouring pillars to create a wall down the length of the
vessel, splitting one large capillary into two smaller daughter capillaries (Mentzer
and Konerding, 2014). While this phenomenon has been previously reported in a
number of different tissues, including the mammalian retina, kidney, lung and
tumour (Taylor et al., 2010; Hlushchuk et al., 2017; Hlushchuk, et al., 2008), little
is known about the biochemical and mechanical regulation of intussusceptive
angiogenesis.
Our research group has recently uncovered novel information on
intussusceptive angiogenesis in ischemic skeletal muscle (Arpino, 2017b). We
utilized a mouse model of PAD with the excision of the hindlimb femoral artery to
characterize regenerative angiogenesis in ischemic skeletal muscle and
discovered a high incidence of transluminal EC pillars within the early stages of
microvascular regeneration. This finding suggests that regeneration of the
microvasculature within the ischemic hindlimb skeletal muscle may be largely
dependent on intussusceptive angiogenesis. Furthermore, we observed that
pillar-bearing vessels exhibited a drastic decrease in blood flow and shear stress
compared with normal capillaries. Endothelial cells possess the unique ability to
sense and respond to changes in the mechanical force caused by flowing blood,
known as shear stress, using a variety of shear stress sensors (Ando and
Yamamoto, 2013). Our findings could therefore suggest that a decrease in shear
stress within a given vessel could be necessary for blood vessel growth via the
process of intussusceptive angiogenesis.
However, ex vivo models for studying EC transluminal pillar formation and
its relationship to shear stress are not available. There are several ex vivo
models to study fluid shear stress, most commonly parallel plate flow systems,
and lab-on-a-chip devices, wherein cells are grown on the surface of a
microchannel physiologically similar in size to microvessels, but studied largely
using only the bottom surface of the channel (Wong et al., 2017; Varma and
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Voldman, 2015). These designs are therefore 2D and consequently lack the 3D
geometry needed for pillar formation. Therefore, development of a novel 3D
system to study endothelial responses to shear stress is required to directly study
this EC phenomenon.
Herein, we report the development of a novel 3D in vitro microvessel
model using microfluidics capable of creating EC transluminal pillars and
enabling the study of mechanisms of pillar formation. We report an increase in
pillar formation under ultra-low shear stress conditions that mimic the flow in
early-stage

regenerative

microvessels

in

ischemic

muscle.

We

further

characterize the expression and localization of select shear stress sensors such
as primary cilia, and the activation of vascular endothelial growth factor receptor
2 (VEGFR2) under ultra-low shear stress conditions. The findings uncover novel
information on the regulation of EC transluminal pillar formation that could have
implications for microvascular network growth and repair in injured tissues.

2.2 Methods
2.2.1 Microfluidic Device Design and Fabrication
The microfluidic device used in these experiments was designed in
collaboration with the Poepping and Holdsworth Labs at the University of
Western Ontario. The master mold of the device was made of acrylic and
generated by the Machine Shop at the University of Western Ontario via micromilling. The device was designed to contain three parallel channels 100 µm in
width, 100 µm in height, and 1 cm in length, although only two channels were
used in any given experiment. Each channel also contained a circular inlet and
outlet. Microfluidic devices were generated using a silicone-based organic
polymer called polydimethylsiloxane (PDMS). A negative of the master mold was
generated using a 10:1 mixture of PDMS elastomer base (10 g, Sylgard184,
Sigma) and silicone curing agent (1 g, Sylgard184, Sigma) and fashioned to a 35
mm glass-bottom dish (MatTek) coated in a thin layer of PDMS semi-cured using
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a hot plate set to 60º. Polyethylene tubing (IntramedicTM, 0.5 mm, BD
Biosciences) cut at 45º was then inserted into the inlet and outlet of the
microchannels.
Before cell culture, microchannels were washed with PBS to remove any
debris and/or air within the channel. The two channels were then coated with 250
µg/mL bovine plasma fibronectin (Sigma, F1141) in an incubator at 37ºC and 5%
CO2 via programmable syringe pumps (NE-300, New Era Pump Systems, Inc.).
The microchannels were then washed with Endothelial Growth Media-2 (EGM-2)
supplemented with EGM-2 Bullet kit (CC-3156, Lonza) containing 0.1 µg/mL Lascorbic acid (A4034, Sigma) via syringe pump set 1 µL/min to create an
environment conducive to cell attachment and growth. The device remained in an
incubator at 37ºC and 5% CO2 until perfusion of the cell suspension.
2.2.2 Endothelialization of Microfluidic Channels
Human umbilical vein endothelial cells (HUVECs; Lonza) were grown in
EGM-2 containing GibcoTM Amphotericin B (1:500, ThermoFisher Scientific) on
10 mm culture dishes (Corning) in an incubator at 37ºC and 5% CO2. HUVECs
were used to develop the microfluidic model because they were relatively easy to
grow within the channels where volume to surface area ratio is low. Between 3-6
passages, HUVECs were trypsinized and resuspended in a mixture of 8%
Dextran in EGM-2 supplemented with L-ascorbic acid to create a cell suspension
at a concentration of 1x107 cells/mL used for seeding one microfluidic channel.
Cells were then infused into the channel by hand, guided by Hoffman modulation
phase contrast microscopy (Axiovert S100 with Hoffman Modulation Contrast,
Zeiss), allowing for visualization and control of the flow of cells within the channel
in order to increase cell adherence. The microfluidic device was left stationary at
37ºC and 5% CO2 for one hour, after which channels were washed by hand with
fresh EGM-2 supplemented with L-ascorbic acid before being left stationary at
37ºC and 5% CO2 for 24 h.
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2.2.3 Induction and Variation of Shear Stress within Microfluidic Channels
Once both microfluidic channels reached 100% confluency, the channels
were connected to programmable syringe pumps and pre-conditioned with EGM2 degassed in a vacuum dessicator (Bel-ArtTM) and delivered at a flow rate of 1
µL/min, corresponding to a shear stress of 1 dyn/cm2, for 1-4 days to allow cells
to become accustomed to moderate flow. The flow rate was then adjusted to 10
µL/min, 0.2 µL/min, or 1 µL/hr, corresponding to shear stresses of 10 dyn/cm2,
0.2 dyn/cm2, and 0.02 dyn/cm2, respectively, or left at 1 dyn/cm2. Shear stress
was calculated using an equation for parallel-plate flow chambers derived from
the Navier-Stokes and continuity equations (Ahsan and Nerem, 2010). The
viscosity of culture medium used was 0.0078 cPoise (dela Paz et al., 2012).
Importantly, the device remained inside the incubator during the entire procedure
to prevent temperature fluctuation-induced air bubbles that could result in cell
death. Cells were subjected to experimental shear stress for 24-48 hours,
followed by immunostaining.
2.2.4 Immunostaining of Endothelial Cells Lining Microfluidic Channels
Cells lining all four walls of each channel were fixed by delivery of 4%
paraformaldehyde (Alfa Aesar, A11313) using programmable syringe pumps at 1
µL/min at room temperature for 25 min. The cells were then permeabilized by
delivering 0.1% or 0.5% Triton-X 100 (Sigma, T8787) in PBS at 1 µL/min for 15
min, after which the solution was left static inside the channels for an additional
15 min. Blocking was performed by delivery of 5% donkey serum at 1 µL/min for
15 min before the blocking solution was left stationary in the device for 1.5-2 hr.
Endothelial cell-cell junctions were immunostained by delivery of rabbit
monoclonal anti-human VE-Cadherin primary antibody (1:200, Cell Signaling
Technologies, D87F2) at 1 µL/min for 15 min. The device was placed on a flat
surface and empty 1 mL syringes were attached to the inlet and outlet tubing of
both channels. The syringes were taped in place to ensure equal tubing height to
reduce residual flow within the channel. The device was stored in static
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conditions overnight at 4ºC. After 24 hr, HUVECs were washed by infusion of
PBS at 1 µL/min for 30 min. The VE-Cadherin cell-cell junctions were visualized
using Alexa Fluor-546 (1:400, Life Technologies, A10040) or DyLight-550 (1:400,
Abcam, ab96920) conjugated donkey anti-rabbit IgG perfused at 1 µL/min for 15
min. The secondary antibody was left static at room temperature for 2 hr and
then washed by delivery of PBS at 1 µL/min for 30 min. Next, the F-actin
cytoskeleton was visualized by perfusion of Alexa Fluor-488 conjugated
phalloidin (1:30 or 1:40, Invitrogen, A12379) at 1 µL/min for 15 min, followed by a
washing step via infusion of PBS for 30 min. Finally, the nuclei were visualized
using either DAPI (1000 nM, Sigma, D9542) or DRAQ5TM (1:200 or 1:500,
ThermoFisher Scientific, 62254) and Fluoromount-G (SouthernBiotech, 0100-01)
was perfused through the channel for 25 min.
The immunostaining methods listed above were also used to visualize
primary cilia, and phosphorylated VEGFR2 (pVEGFR2). To locate primary cilia, a
protein localized to the axoneme of cilia called ADP-ribosylation factor-like
protein 13b (ARL13b) was immunostained by delivery of rabbit polyclonal antihuman ARL13b primary antibody (1:400, Proteintech, 17711-1-AP) and
visualized using DyLight-550 conjugated donkey anti-rabbit IgG (1:200).
Phosphorylated VEGFR2 was immunostained by delivery of rabbit polyclonal
anti-human VEGFR2 (phospho Y1054 + Y1059) primary antibody (1:100, Abcam,
ab5473). The receptor was visualized using DyLight-550 conjugated donkey antirabbit IgG (1:100).
2.2.5 Confocal Imaging and Analysis of Endothelial Cell Morphology and
Pillar Formation
Endothelial cells lining all four walls of the microfluidic channels were
imaged using a Leica TCS SP8 Confocal Microscope using a 40x oil-immersion
objective and Diode 405, OPSL 488, and OPSL 552 lasers or a Nikon A1R
Confocal Laser Scanning System using a 40x oil-immersion objective and
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405nm, 488nm, 561nm, and 647nm lasers. Seven fields of view (FOV) were
taken down the length of each channel, beginning 1 mm from the channel inlet
and moving toward the channel outlet. Regions of interest imaged using the
Galvano or Resonance scanner from the Nikon microscope were generated
using up to 120, 0.3 µm-thick z-slices at a pixel resolution of 300 nm. Z-slices
were reconstructed using Image Viewer (Leica) or NIS Elements Software
(Nikon) into 3D volume images, as well as maximum intensity planar projections
showing only the bottom surface of the channel, and orthogonal projections.
Endothelial cell elongation in the direction of flow was evaluated
quantitatively under each shear stress condition, whether 10 dyn/cm2, 1 dyn/cm2,
0.2 dyn/cm2, or 0.02 dyn/cm2, by measuring both the length of each cell in the
direction of flow and the aspect ratio of each cell. The maximum intensity planar
projection of 7 FOVs was used to outline each individual cell and, using the
“Centroid” and “Fit ellipse” tools in ImageJ (NIH), the major axis and minor axis
through the centroid of the cell area were measured and divided to generate the
aspect ratio. The length of each cell was quantified by measuring the length of
each cell along the flow axis.
Alignment of ECs in the direction of flow was evaluated quantitatively by
measuring the angular deviation of both the cell axis and the nuclear axis from
the axis of flow. To measure angular deviation of the cell axis from the axis of
flow, the intracellular area of each cell was again outlined in ImageJ (NIH) and,
using the “Centroid” and “Fit ellipse” tools, the major axis was calculated and the
angle between the major axis and the x-axis of the image, in this case set to be
the axis of flow. Angular deviation of the nuclear axis from the axis of flow was
measured by hand using the “Angle” tool in ImageJ, quantifying the angle
between the long axis of each cell nucleus and the axis of flow.
Endothelial cell F-actin, ARL13b, and pVEGFR2 content was quantified
using background-corrected integrated density measurements. When measuring
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F-actin and ARL13b content, the intracellular area of each cell in the maximum
intensity projection was outlined following the internal border of each cell in
ImageJ to ensure no cortical F-actin was measured. When measuring F-actin
content, 5-7 FOVs were used and, when measuring ARL13b and pVEGFR2 were
being measured, 7 FOVs were used. Then, the channels were split, and the
areas outlined were imported onto the green channel image when measuring Factin and red channel image when measuring ARL13b. When measuring
pVEGFR2 content, the border of each cell was outlined to measure the content
of the cellular junctions. The area and integrated density of each outlined cell
were generated using the “Integrated Density” and “Area” tools. Then, a random
area outside of the channel walls was measured for background using the “Mean
Grey Value” tool. Finally, the corrected integrated density was generated using
the following equation: Integrated Density – (Mean Grey Value*Area).
Pillar frequency within the channels was quantified using the seven
equidistant regions of interest down the length of each channel exposed to both 1
dyn/cm2 and 0.02 dyn/cm2. The 3D volume reconstructions of each FOV of
dimensions 206.21 µm x 318.01 µm x 45.00 µm (XYZ) were used to determine
the number of cells forming a pillar and the number of cells not participating in a
pillar. The number of cells participating in a pillar was then divided by the total
number of cells on the bottom surface of the channel to generate the pillar
frequency.
2.2.6 Statistical Analysis
All data sets were tested for normality using a D’Agostino and Pearson
omnibus normality test and none were shown to be normally distributed.
Comparisons were made among all four shear stress conditions using a KruskalWallis test with Dunn’s post hoc test using Graphpad Prism. Comparisons among
pillar frequency and the integrated densities of ARL13b and pVEGFR2 were
made using a Mann-Whitney test. Statistical significance was set at p<0.05.
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2.3 Results
2.3.1 Engineering of a Novel 3D Microvessel Model
In order to study the effects of shear stress on EC transluminal pillar
formation, we developed a 3D in vitro model of a microvessel using a microfluidic
device containing two channels 100 µm in height, 100 µm in width, and 1 cm in
length (Figure 2.1 A-B). A square channel geometry was developed to allow
close proximity of the channel walls, creating an environment where pillar
formation could occur. Each channel was circumferentially lined with a monolayer
of endothelial cells and fluorescently stained to visualize the F-actin cytoskeleton,
VE-cadherin intercellular junctions, and nuclei using laser-scanning confocal
microscopy (Figure 2.1 C).
Healthy ECs are known to respond to high shear stress by elongating and
aligning in the direction of flow in vivo (Tzima et al., 2005). We found that
HUVECs lining the microfluidic channels subjected to a high shear stress of 10
dyn/cm2, a shear stress seen in capillaries in vivo, underwent such an alignment.
That is, cells appeared elongated in shape and aligned in the direction of flow.
This was associated with cells having an abundance of F-actin stress fibres,
which were similarly aligned in the direction of flow (Figure 2.2). These findings
indicated healthy EC monolayers lining the microfluidic device capable of
responding to physiologic shear stress.
2.3.2 Ultra-Low Shear Stress Induces Endothelial Cell Rounding
Following the construction and optimization of our 3D microvessel model,
we looked to examine the morphological responses of ECs under a range of
shear stress conditions. To accomplish this, we subjected ECs to four shear
stress conditions, including ultra-low shear: 10 dyn/cm2, 1 dyn/cm2, 0.2 dyn/cm2,
and 0.02 dyn/cm2 (Figure 2.3). EC morphology and elongation in the direction of
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Figure 2.1 3D microvessel modelling using a microfluidic device.
A-B. Generation of a microfluidic device entails design and fabrication of a
microfluidic master mold containing three channels 100 µm in height, 100 µm in
width, and 1 cm in length, each beginning with an inlet and ending with an outlet.
A negative mold of these channels is then developed using cured PDMS, which
is attached to a glass-bottom dish spin-coated with a thin layer of PDMS. Tubing
is inserted to the inlet and outlet of two channels to allow perfusion of fluids
through the microfluidic channels. C. A 3D volume image (XYZ) reconstructed
from 365 confocal z-slices showing HUVECs immunostained for VE-Cadherin
and stained for F-actin lining all four walls of the microfluidic channel.
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Figure 2.2 Generation of a healthy endothelial cell monolayer within a
microfluidic channel.
Confocal planar projection images (XY) of HUVECs lining the bottom surface of a
microfluidic channel immunostained for VE-Cadherin and stained to visualize Factin and nuclei (120 z-slices, 0.25 µm step-size) showing healthy ECs capable
of responding to high shear stress of 10 dyn/cm2 by elongating and aligning in
the direction of flow, with a high number of F-actin stress fibres.
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Figure 2.3 Morphology and cytoskeletal reorganization in response to
decrements of laminar shear stress.
HUVECs lining the bottom surface of a microfluidic device revealed using
confocal planar projection images (XY) stained to visualize F-actin cytoskeleton
(upper row) and immunostained for VE-Cadherin (middle row) (120 z-slices, 0.25
µm step-size). Cells exposed to physiologically relevant shear stress conditions
of 10 dyn/cm2 and 1 dyn/cm2 (first and second columns, respectively) showed
typical EC morphology under high shear stress, appearing elongated in shape
and aligned in the direction of flow with high number of F-actin stress fibres.
Cells exposed to ultra-low shear stress conditions of 0.2 dyn/cm2 and 0.02
dyn/cm2 (third and fourth columns, respectively) showed a decrease in
elongation and alignment with the direction of flow, instead appearing rounded in
shape and more randomly oriented. Under these conditions, the F-actin
cytoskeleton was reorganized from F-actin stress fibres to cortical actin bordering
the cell-cell junctions.
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flow were quantified by measuring the length of each cell in the direction of flow
and the cellular aspect ratio. Cells exposed to physiologic shear stress of 10
dyn/cm2 displayed a median cell length of 78.7 µm (IQR = 63.7 µm to 100.8 µm).
Under 1 dyn/cm2 the median cell length was also 69.04 µm (IQR = 55.5 µm to
85.1 µm, Figure 2.4 A). Cells exposed to 0.2 dyn/cm2 (56.2 µm, IQR = 47.2 µm to
72.1 µm) and 0.02 dyn/cm2 (56.9 µm, IQR = 46.5 µm to 70.0 µm) showed a 28%
and 19% decrease in median cell length when compared to 10 dyn/cm2 and 1
dyn/cm2, respectively (p<0.0001).Quantitative analysis of cellular aspect ratio
revealed a similar trend. Cells exposed to physiologic shear stress of 10 dyn/cm2
and 1 dyn/cm2 had a median aspect ratio of 4.2 (IQR = 2.9 to 6.0) and 3.3 (IQR =
2.3 to 4.6), respectively (Figure 2.4 B). Cells exposed to 0.2 dyn/cm2 experienced
a 25% and 18% decrease in aspect ratio compared to 10 dyn/cm2 and 1 dyn/cm2
(IQR = 2.1 to 3.9, p<0.0001), respectively. A similar reduction was seen in cells
exposed to 0.02 dyn/cm2 (IQR = 1.8 to 3.3, p<0.0001). These results reveal that
cells become rounder and less elongated as shear stress decreases.
Nevertheless, they remained viable and adherent to the channels walls.
2.3.3 Ultra-Low Shear Stress Causes Reorganization of the F-Actin
Cytoskeleton
In response to decreased shear stress, we observed a shift in the F-actin
cytoskeleton organization of HUVECs in micro-channels. Specifically, cells
exposed to higher shear showed a high number of thick F-actin stress fibres.
However, as shear decreased, the number of F-actin stress fibres progressively
decreased. Instead, cortical actin lining the border of each cell became prominent
(Figure 2.3). Quantitative analysis of intracellular F-actin showed that exposure to
a shear of 0.2 dyn/cm2 results in a 37% and 36% decrease compared to 10 and
1 dyn/cm2, respectively (p=0.0001, p<0.0001) (Figure 2.4 C). A 21% and 19%
reduction in F-actin content was seen when cells were exposed to shear stress of
0.02 dyn/cm2 (p<0.0001, p=0.0177). A shear of 0.02 dyn/cm2 led to a slight
peculiar increase of F-actin content as compared with 0.2 dyn/cm2 (p<0.0001).
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Figure 2.4 Endothelial cell changes in morphology under various shear
stress conditions.
A. Graph depicting changes in length of the cell in the direction of flow at 10
dyn/cm2 (n=348 ECs), 1 dyn/cm2 (n=345 ECs), 0.2 dyn/cm2 (n=372 ECs), and
0.02 dyn/cm2 (n=345 ECs). B. Scatter plot showing cell aspect ratio determined
by the length of the major axis of the cell divided by the minor axis at 10 dyn/cm2
(n=348 ECs), 1 dyn/cm2 (n=322 ECs), 0.2 dyn/cm2 (n=373 ECs), and 0.02
dyn/cm2 (n=345 ECs). C. Plot depicting the presence of F-actin stress fibres
quantified using intracellular F-actin content at 10 dyn/cm2 (n=284 ECs), 1
dyn/cm2 (n=283 ECs), 0.2 dyn/cm2 (n=307 ECs), and 0.02 dyn/cm2 (n=283 ECs).
D-E. Graphs showing angular deviation of the nucleus of cells from the direction
of flow at 10 dyn/cm2 (n=396 ECs), 1 dyn/cm2 (n=377 ECs), 0.2 dyn/cm2 (n=382
ECs), and 0.02 dyn/cm2 (n=376 ECs), as well as angular deviation of the major
axis of the cell from the direction of flow at 10 dyn/cm2 (n=347 ECs), 1 dyn/cm2
(n=345 ECs), 0.2 dyn/cm2 (n=373 ECs), and 0.02 dyn/cm2 (n=345 ECs). All
graphs were generated using data from 3 microfluidic channels per shear stress
condition.
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These results reflect the decrease in F-actin stress fibres seen in cells exposed
to ultra-low shear stress.
2.3.4 Endothelial Cells Exposed to Ultra-Low Shear Stress Become
Randomly Oriented in the Direction of Flow
We next evaluated EC alignment in the direction of flow among the
various shear stress conditions. To do so, I measured the angular deviation of
the long axis of the cell nucleus from the axis of flow, as well as the angular
deviation of the major axis of the cell body from the axis of flow. Cells exposed to
physiologic shear stress conditions of 10 dyn/cm2 and 1 dyn/cm2 showed a
median nuclear angular deviation of 13.4º (IQR = 6.0º to 26.6º) and 14.3º (IQR =
6.3º to 27.9º), respectively (Figure 2.4 D). The angle of the nuclear axis of cells
exposed to 0.2 dyn/cm2 showed respective 63% and 53% increases when
compared to cells subjected to 10 dyn/cm2 and 1 dyn/cm2. (IQR = 10.6º to 41.1º,
p<0.0001). Cells exposed to 0.02 dyn/cm2 experienced a 75% and 64% increase
in nuclear angular deviation when compared to the higher shear stress conditions
(IQR = 12.9º to 40.2º, p<0.0001).
Quantitative analysis of the angular deviation of the major axis of the cell
body from the direction of flow also revealed more randomly oriented ECs as
shear stress decreased. When exposed to 10 dyn/cm2 and 1 dyn/cm2, cells
showed a median angular deviation of 10.0º (IQR = 4.8º to 17.8º) and 9.34º (IQR
= 4.3º to 17.9º), respectively (Figure 2.4 E). When exposed to 0.2 dyn/cm2, cells
showed a median angular deviation of 11.8º (IQR = 5.2º to 21.6º). Cells exposed
to 0.02 dyn/cm2 showed a 64% and 75% increase in angular deviation of the cell
axis when compared to 10 dyn/cm2 and 1 dyn/cm2, respectively (IQR = 7.4º to
28.6º, p<0.0001). Interestingly, cells subjected to 0.02 dyn/cm2 also had a 38%
increase in angular deviation compared to cells exposed to 0.2 dyn/cm2
(p=0.0004). Taken together, these results show an overall increase in angular
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deviation from the direction of flow and generally more random orientation in cells
exposed to ultra-low shear stress.
2.3.5

Ultra-Low

Shear

Stress

is

Conducive

to

Endothelial

Cell

Transluminal Pillar Formation
Next, we sought to determine if the microfluidic model was capable of
recreating an EC transluminal pillar. To accomplish this, HUVECs exposed to 1
dyn/cm2 and 0.02 dyn/cm2 were visualized using both orthogonal and 3D volume
reconstructions of confocal z-slices. Remarkably, these orthogonal and volume
images revealed a number of transluminal pillars. These appeared as
endothelial-based projection that crossed from one side of the lumen to the other,
connecting cells on the bottom surface to cells lining the wall of the microfluidic
channel (Figure 2.5 A-B). Remarkably, we also observed multiple pillars formed
within the same region of interest within the microfluidic channel (Figure 2.5 B,
see Online Video 4.1in Appendix A). Interestingly, filopodial projections varied in
morphology–81% of pillars appeared as thin F-actin protrusions crossing the
lumen, while the other 19% appeared wider, having extended down the long axis
of the channel, often with a nucleus participating within the filopodial structure
(Figure 2.5 B). Wider pillars also experienced some overlap, suggesting fusing of
neighbouring pillars.
We next sought to compare the prevalence of pillar formation under each
of the shear stress conditions. ECs subjected to physiologic flow showed a mean
pillar prevalence of 0.6% (Figure 2.5 C). Interestingly, quantitative analysis of EC
pillar prevalence showed an 8.8-fold increase in pillar formation under ultra-low
shear stress conditions (p<0.0001). This finding reveals that ultra-low shear
stress facilitates EC transluminal pillar formation.
2.3.6 Ultra-Low Shear Stress Leads to an Increase in ARL13b Expression
Primary cilia are extracellular structures found on the surface of cells
composed of microtubules that are widely thought to act as shear stress sensors.
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Figure 2.5 Recreation of a transluminal pillar under ultra-low shear stress in
a 3D in vitro microvessel model.
A. Confocal orthogonal projections (XZ) depicting HUVECs exposed to 0.02
dyn/cm2 lining the bottom and side walls of a microfluidic channel immunostained
for VE-Cadherin (red) and stained to visualize F-actin (green). Endothelial cell
transluminal pillars formed across the channel lumen stretching from the bottom
surface to the side wall (arrows), with and without the presence of a nucleus
within the pillar (top and middle rows versus bottom row, respectively). B-C. 3D
volume images (XYZ) reconstructed from confocal z-slices (120 z-slices, 0.25 µm
step-size) showing multiple transluminal pillars formed within one region of
interest (arrows) (B, see Online video 4.1 in Appendix A), as well as pillars
widened down the long axis of the channel and beginning to overlap at the base
of the pillars (arrow) (C). D. Bar graph depicting transluminal pillar frequency,
calculated as the number of cells participating in a pillar divided by the total
number of cells within a microfluidic channel across 7 FOVs, showing an
increase in EC pillar formation under ultra-low flow (p<0.0001, n=4 microfluidic
channels per shear stress condition).
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ADP-ribosylation factor-like protein 13b (ARL13b) is a GTPase localized along
the axoneme of these cilia and is responsible for F-actin cytoskeleton
reorganization via the Sonic hedgehog (Shh) pathway (Caspary et al., 2007;
Renault et al., 2010). Given that the role of primary cilia as a shear stress sensor
has been studied mainly under high shear stress conditions (Ando and
Yamamoto, 2013), we asked whether these could sense ultra-low shear stress.
By immunostaining for ARL13b, we identified primary cilia under a shear stress
of 1 dyn/cm2 and an ultra-low shear stress of 0.02 dyn/cm2. Notably, we
observed a 1.9-fold increase in ARL13b content under the ultra-low shear
condition (Figure 2.6 A-B). This finding indicates that endothelial primary
ciliogenesis is stimulated by ultra-low shear, potentially increasing the cell’s
sensitivity to this force.
Most intriguing was the identification and localization of ARL13b within the
EC transluminal pillar structure. When scrutinizing a 3D volume image, we
observed ARL13b localized to a primary cilium above the nucleus within a pillar
bridging across the microfluidic channel lumen (Figure 2.6 C), suggesting the
presence of a primary cilium protruding out of the pillar. However, ARL13b was
only associated with pillars larger in width as opposed to thinner strands of
pillars. This novel information concerning primary cilium localization within a
transluminal pillar could uncover a potential active, spatially-specific role for
these cilia in pillar formation.
2.3.7 Ultra-Low Shear Stress Results in a Decrease in Phosphorylated
VEGFR2
We next sought to determine the change in activation of VEGFR2 by
phosphorylation. To do so, we subjected ECs lining the microfluidic device to
shear stress conditions of 1 dyn/cm2 and an ultra-low shear stress of 0.02
dyn/cm2. Immunostaining of phosphorylated VEGFR2 (pVEGFR2) revealed
signal along the borders of ECs at cell-cell junctions. Notably, we observed a
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Figure 2.6 Increase in ARL13b expression in HUVECs exposed to ultra-low
shear stress.
A. Confocal planar projection images (XY) of HUVECs lining the bottom surface
of microfluidic channels immunostained for ARL13b (red) and stained to visualize
the F-actin cytoskeleton (green) showing an increase in ARL13b expression
under ultra-low shear stress of 0.02 dyn/cm2 (120 z-slices, 0.25 µm step size). B.
Graph depicting ARL13b content in cells exposed to 1 dyn/cm2 (n=408 ECs) and
0.02 dyn/cm2 (n=360 ECs) (p<0.0001, n=3 microfluidic channels per shear stress
condition). C. A 3D volume image (XYZ) reconstructed from confocal z-slices
depicting a transluminal pillar with localized ARL13b (arrow) extending from the
bottom surface to the side wall of an EC-lined microfluidic channel.
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statistically discernible 22% decrease in pVEGFR2 abundance in cells exposed
to ultra-low shear stress conditions compared to cells exposed to 1 dyn/cm2
(p<0.0001, Figure 2.7 A-B). Of note, this decrease in pVEGFR2 suggests
activation of VEGFR2 is positively correlated with shear stress magnitude in my
microfluidic design. This adds to and is consistent with the previous report that
increased laminar shear activates VEGFR2 (Tzima et al., 2005).
Interestingly, pVEGFR2 immunoreactivity was also observed at EC
transluminal

pillars.

To

accurately

study

pVEGFR2

localization

within

transluminal pillars, 3D volume images of regions of interest were reconstructed
using z-slices taken using confocal laser scanning. These images revealed
pVEGFR2 staining localized to the middle region of the pillar away from either
end of the pillar-wall interface (Figure 2.7 C). Moreover, this signal appeared to
be lateralized to the upstream side the pillar bridging the channel lumen (Figure
2.7 D). This finding of localized and lateralized pVEGFR2 expression within
transluminal pillars outlines a potential role for VEGFR2 in pillar morphogenesis,
especially

after

initial

stage

of

pillar

formation.

59

Figure 2.7 Ultra-low shear stress results in a decrease in pVEGFR2
expression in endothelial cells lining a 3D microfluidic channel.
A. Confocal planar projection images (XY) of ECs lining the bottom surface of
microfluidic channels immunostained for pVEGFR2 (red) and stained to visualize
the F-actin cytoskeleton (green). pVEGFR2 appears along the border of cells,
overlapping cell-cell junctions (120 z-slices, 0.25 µm step size). B. Graph
depicting pVEGFR2 content quantified within endothelial cell-cell junctions
showing a decrease in pVEGFR2 expression in cells under ultra-low shear stress
of 0.02 dyn/cm2 (n=211 ECs) compared to 1 dyn/cm2 (n=214 ECs) (p<0.0001,
n=2 microfluidic channels per shear stress condition). C-D. 3D volume images
(XYZ) reconstructed from 120 confocal z-slices (0.25 µm step-size) showing the
presence of pVEGFR2 in the mid-region of a transluminal pillar (arrow) (C)
lateralized to the upstream side of the pillar (D) extending from the bottom
surface to the side wall of a microfluidic channel circumferentially lined with ECs.
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2.4 Discussion
Regenerative angiogenesis in the context of ischemic injury has recently
been determined by our research group to rely on intussusceptive angiogenesis,
discernible by the formation of endothelial transluminal pillars (Arpino, 2017b).
Moreover, vessels undergoing intussusception also experienced a pronounced
decrease in blood flow and, consequently, shear stress. However, the
biochemical and biomechanical regulation of this growth process remains poorly
understood. In this study, we developed a novel 3D microvessel model capable
of forming pillars and elucidating the regulation of EC transluminal pillar
formation. Notably, we report an 8.8-fold increase in transluminal pillar formation
under ultra-low shear stress conditions. This suggests ultra-low shear stress is
permissive to the progression of intussusception angiogenesis via pillar
formation.
The model developed in this study uses a square channel design that
approximates microvessel physiology in terms of size. Our model is also unique
in that cells line all four surfaces of the channel to create a contiguous 3D
structure wherein the opposing cells monolayers are close enough in proximity to
resemble a microvessel. Despite the expansion of the field of microfluidics, there
remains a large variation in both the size and geometry of microchannels used to
study EC flow response. Many research groups make use of rectangular
channels, using the channel height to reflect microvessel physiology and
increasing the width of the channel to offset pressure introduced by high flow
rates (Park et al., 2019; Reinitz et al., 2015; Sakurai et al., 2018). Moreover, the
majority of microfluidics studies concentrate on cells lining the bottom surface of
the channel, generating 2D models indicative of changes in the EC monolayer,
but not in the channel as a whole (Shih et al., 2019; Maoz, et al., 2018). The
system developed herein not only allows for the controlled study of EC response
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to shear stress, but also accounts for the communication between cells not only
adjacent but physically opposing each other as would be the case in vivo.
Among 3D microfluidic microvessel models, most commonly studied is
endothelial response to high shear stress conditions seen within healthy
microvascular networks. Under these conditions, ECs have been shown to
elongate and align in the direction of flow (Tzima et al., 2005). Our findings of EC
morphology changes under low shear are consistent with prior data. A vascular
cast study by Langille and Adamson (1981) of rabbit and mouse arterial branch
sites showed ECs lacked orientation and appeared rounded in shape in areas of
low shear stress. Moreover, our finding of cytoskeletal reorganization from Factin stress fibres to cortical actin under low shear stress conditions echoes a
recent study of ECs within a microfluidic channel (Inglebert et al., 2020).
However, these studies, both in vivo and ex vivo, concentrate on low shear
stress either in areas of turbulent flow or in conditions of laminar flow of 2-4
dyn/cm2. Therefore, while similar findings were seen within the low shear stress
conditions of our ex vivo microvessel model, the study of EC response to shear
stress below 1 dyn/cm2 is lacking, with only one study by Park et al. (2011),
interestingly using microfluidics, interrogating shear stress at this magnitude.
The 3D microvessel model developed in this study represents the first ex
vivo model to achieve suitable conditions for controlled endothelial transluminal
pillar formation. While the existence of transluminal pillars as a marker of
intussusception has been known for many years, the role of shear stress in the
formation of these pillars has only recently become a focus. Some studies have
suggested that acute increases in shear stress rapidly lead to transluminal pillar
formation and subsequent vessel splitting in mouse skeletal muscle (GiannaBarrera et al., 2013). Computational studies in chick chorioallantoic membrane
(CAM) models of adaptive angiogenesis have suggested that pillars form in
zones where shear stress is <1 dyn/cm2, constrained by regions of high shear
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stress (Lee et al., 2011). However, in vitro models capable of recreating a 3D
transluminal pillar have not yet been established. Therefore, the finding of
increased pillar frequency under an ultra-low shear stress of 0.02 dyn/cm2 is the
first to definitively and directly confirm the role of low shear stress in pillar
formation.
The progression of intussusceptive angiogenesis is widely understood to
involve the formation of multiple pillars down the length of a single vessel. These
pillars will then enlarge to extend down the length of the vessel, fusing with
adjacent pillars to fully split the vessel into two daughter vessels (Gianna-Barrera
et al., 2013). Interestingly, the transluminal pillars seen in our 3D microvessel
model showed a variation in size and thickness that could be representative of
the enlargement of pillars as seen in vivo. In this case, thin filopodial projections
would represent the beginning stages of intussusception wherein the pillar had
first formed. Moreover, endothelial projections or bridges that had widened along
the long axis of the microfluidic channel and contained a nucleus may represent
pillars that had begun to enlarge. We also observed overlapping of these
widened pillars that could reflect the fusing of neighbouring pillars. Furthermore,
we observed multiple pillars of varying thickness within the same region of
interest, reflective of the process that occurs in vivo. The observations in our
microvessel model closely mimic what has been reported in vivo, which presents
the first physiologically relevant, controlled method of studying not only a single
transluminal

pillar,

but

potentially

the

progression

of

intussusceptive

angiogenesis via pillar formation and fusion.
Following interrogation of the biomechanical regulation of EC transluminal
pillar formation by shear stress, I discovered novel information concerning the
biochemical regulation of pillar formation. Specifically, I observed an increase in
the abundance of primary cilia marker ARL13b in ECs subjected to ultra-low
shear stress. Primary cilia are extracellular rod-like structures on the plasma
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membrane of cells, composed of microtubule doublets, forming what is called an
axoneme, connected to a microtubule organizing centre. ARL13b, the protein
used to visualize the localization of these cilia, is a GTPase located along the
axoneme and is responsible for regulating Shh signalling (Caspary et al., 2007).
Non-canonical Shh signalling leads to reorganization of the actin cytoskeleton
(Renault et al., 2010). These structures have been suggested to act as shear
stress sensors on ECs, helping to trigger signalling cascades relaying changes in
shear stress magnitude and direction to the cell via bending of the cilia (Ando
and Yamamoto, 2013). The increase in ARL13b observed here suggests an
increase in either the number of ARL13b GTPases lining a single primary cilium
or an increase in the number of primary cilia themselves. Interestingly, studies
within the chicken embryonic endocardium as well as the vasculature of the
mouse retina reported a similar increase in number as well as length of primary
cilia under low shear stress (Van der Heiden et al. 2005; Vion et al. 2018). It is
tempting to consider the possibility of a role for primary cilia in the establishment
of flow-seeking behaviour in ECs exposed to ultra-low shear stress. A decrease
in shear stress corresponding to an increase in primary cilia suggests a
mechanism by which the cell increases its capacity to sense shear stress under
ultra-low conditions by increasing the number of flow-sensing structures on its
plasma membrane.
I also discovered accumulation of ARL13b within the structure of the pillar
itself. This novel finding further implicates a role for primary cilia in the formation
or maintenance of EC transluminal pillars. In fact, this finding could support the
establishment of flow-seeking behaviour in intussusceptive ECs even further. It
could be suggested that under ultra-low shear stress conditions primary cilia
increase in number, creating a flow-seeking behaviour that then guides the
formation of a transluminal pillar. Assuming pillar formation is a protrusive event,
primary cilia could exist to guide the cell body towards the centre of the lumen
where shear stress would be more concentrated. This is further supported by the
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increase in ARL13b observed, as an increase in this protein could magnify shear
stress signalling via primary cilia and lead to the specific reorganization of the Factin cytoskeleton that results in extension of the EC cell body to form a pillar.
It is worth noting, however, that in this study I visualized primary cilia by
means of an antibody against ARL13b, a GTPase localized specifically to along
the axoneme of the primary cilia (Caspary et al., 2007). While this method has
been used in previous studies to identify primary cilia in EC culture (Vion et al.,
2018; Eisa-Beygi et al., 2018), it is important to note that this protein may not
reveal the entire structure of the primary cilia in a 3D capacity. Therefore, while I
can derive the localization of primary cilia within the ECs in this study, I cannot
infer structural information regarding the length or direction of the primary cilia
identified.
Interestingly, in addition to observing a decrease in the activation of
VEGFR2 within HUVECs lining the walls of the channel, localized pVEGFR2 was
discovered within the endothelial-based protrusion of the transluminal pillar.
Specifically, puncta/foci of pVEGFR2 was found within the mid-section of the
pillar, away from either base where the pillar connected to a cell within the
monolayer. Moreover, this pVEGFR2 was lateralized to the side of the pillar
directly facing oncoming flow. This finding suggests a high magnitude of shear
stress along the mid-section of the transluminal pillar due to localized
hemodynamic forces. Computational models of pillars within a flowing vessel
support these findings, demonstrating high shear stress within the mid-section of
the pillar on the upstream side compared to “dead zones” on the downstream
surface and at the pillar-wall interface (Filipovic et al., 2009). Therefore, migration
from the wall, where shear stress is low, to the lumen could further imply a flowseeking behaviour that motivates ECs to undergo intussusceptive angiogenesis,
thereby forming a transluminal pillar.
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In conclusion, we have developed the first in vitro model capable of EC
transluminal

pillar

formation

and

the

progression

of

intussusceptive

angiogenesis. We further utilized this model to demonstrate that ultra-low shear
stress is permissive to pillar formation and uncovered important relationships with
primary cilia and VEGFR2. The findings described help to further elucidate the
regulation of intussusceptive angiogenesis, which is an important but enigmatic
angiogenic process.
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CHAPTER 3:
THE ROLE OF VEGFR2 IN ENDOTHELIAL
TRANSLUMINAL PILLAR FORMATION: A 3D
MICROFLUIDIC STUDY
3.1 Introduction
Ischemic injury is a severe consequence of peripheral arterial disease
(PAD), wherein atherosclerotic plaques within the femoral artery of the leg hinder
oxygen delivery to the downstream skeletal muscle (Annex, 2013). This reduction
in oxygen content also results in damage to the microvasculature responsible for
feeding the tissue. Recently developed strategies used to reperfuse the
deoxygenated skeletal muscle and restore muscle function include therapeutic
angiogenesis, involving induction of angiogenesis in the affected leg and
informed by current knowledge of sprouting angiogenesis (Cooke and Losordo,
2015). However, translation of these therapies from preclinical animal models to
clinical trials has been met with limited success (Iyer and Annex, 2017).
Sprouting angiogenesis is the most well-understood form of angiogenesis
and has been extensively studied to elucidate the biochemical regulation of the
process. Central to the progression of blood vessel growth via this mechanism is
vascular endothelial growth factor receptor 2 (VEGFR2) and its corresponding
ligand vascular endothelial growth factor A (VEGF-A) (Carmeliet, 2000). VEGFA-VEGFR2 binding on the surface of an endothelial cell (EC) lining a pre-existing
blood vessel causes this cell to migrate into the surrounding tissue and lumenize
(Ribatti and Crivellato, 2012).
However, another form of angiogenesis also exists called intussusceptive
angiogenesis (IA), wherein ECs lining opposing sides of a pre-existing vessel
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protrude into the flowing lumen and fuse to create a bridge termed an EC
transluminal pillar. However, the exact biochemical and biomechanical regulation
of this process remains elusive. Interestingly, recent research from our group has
uncovered the importance of this mode of angiogenesis in repairing
microvasculature damaged by ischemic injury in a mouse model of PAD (Arpino,
2017b).
VEGFR2 is known not only for its important role in sprouting angiogenesis,
but also for its importance in shear stress sensing. ECs possess the unique
ability to sense and respond to changes in the force created by the flowing blood,
known as shear stress. These changes result in signalling cascades that
ultimately modulate vascular tone, control cell proliferation, dictate the
organization of the actin cytoskeleton, and more (Ando and Yamamoto, 2013).
VEGFR2 itself forms a critical shear stress sensing complex at the junction of
ECs, along with VE-Cadherin and PECAM-1, which upon stimulation by flow
activates the Src-family kinases to phosphorylate VEGFR2 in a ligandindependent manner and trigger downstream activation of protein kinase B (Akt)
and endothelial nitric oxide synthase (eNOS; Jin et al., 2003). Considered
alongside its essential role in sprouting angiogenesis, the importance of VEGFR2
as a shear stress sensor could point to a potential role for VEGFR2 in
intussusceptive angiogenesis.
Herein, we utilized the 3D microvessel model optimized in Chapter 2 to
generate a co-culture of fluorescently labelled ECs transfected with siRNA
designed to knockdown VEGFR2 or control siRNA. Notably, we report an
increase in transluminal pillar formation in cells with reduced expression of
VEGFR2. This finding uncovers novel information concerning the role of this
essential endothelial cell-specific receptor in intussusceptive angiogenesis.
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3.2 Methods
3.2.1 Microfluidic Device Fabrication
The microfluidic device used herein was designed in collaboration with the
Poepping and Holdsworth Labs at the University of Western Ontario to generate
one microchannel of dimensions 300 µm x 1000 µm x 1 cm (h, w, l). Microfluidic
devices were constructed via soft lithography using a 10:1 mixture of
polydimethylsiloxane (PDMS) elastomer base (10 g, Sylgard184, Sigma) and
silicone curing agent (1 g, Sylgard184, Sigma). The negative mold containing the
patterned PDMS was attached to a 35 mm glass-bottom dish (MatTek) spincoated with a thin layer of PDMS using heat, after which tubing was inserted into
the inlet and outlet of the channel to facilitate perfusion through the channel. Prior
to cell culture, the channel was infused with 250 µg/mL of fibronectin (Sigma) at
37ºC and 5% CO2 using a programmable syringe pump (NE-300, New Era Pump
Systems, Inc.). Fibronectin was then washed from the channels via perfusion of
Microvascular Endothelial Growth Media (EGM-MV) supplemented with EGM-MV
Bulletkit (CC-3125, Lonza) containing 0.1 µg/mL L-ascorbic acid (Sigma) to
prepare for cell seeding.
3.2.2 VEGFR2 Knockdown and Co-Culture of Fluorescent HUVECs in the
Microfluidic Channel
Human umbilical vein endothelial cells (HUVECs) stably expressing either
RFP or GFP (cAP-0001RFP, cAP-0001GFP, Angio-Proteomie) were cultured in
EGM-MV. Upon reaching 60% confluency, passage 4-8 fluorescent HUVECs
were transfected with 42 nM of either KDR/VEGFR2 siRNA or universal
scrambled negative control siRNA (SR302557, SR3004, Origene) using
Lipofectamine RNAiMAX (13778075, ThermoFisher Scientific). The transfection
solution was applied for 6 h before fresh media was delivered and cells were left
to recover at 37ºC and 5% CO2 overnight. Before use in any experiments, the
efficiency of the KDR/VEGFR2 siRNA knockdown was confirmed via reverse
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transcription-quantitative PCR using SYBR Green chemistry and a ViiA 7 Real
Time PCR System (ThermoFisher Scientific). Primers (Origene) for the human
KDR

gene

were

5’-GGAACCTCACTATCCGCAGAGT-3’

and

3’-

CCAAGTTCGTCTTTTCCTGGGC-5’.
Following recovery from transfection, GFP-HUVECs and RFP-HUVECs
were trypsinized and combined in equal amounts and resuspended in a mixture
of EGM-MV and 8% Dextran (Sigma) in EGM-MV supplemented with L-ascorbic
acid to encourage cell adherence to the channel surface. The cell suspension
was generated at a bulk cell concentration of 3x106 cells/mL and injected into the
channel by hand guided by Hoffman modulation phase contrast microscopy
(Axiovert S100 with Hoffman Modulation Contrast, Zeiss) to allow for
visualization and control of the velocity of cells flowing through the channel. After
1 h, fresh media was perfused through the channel by hand and the channel was
then left stationary at 37ºC and 5% CO2 for 24 h to allow for cell growth into a
complete EC monolayer. Similar methods were used for culture of nonfluorescent HUVECs within the microfluidic channel to assess the health of ECs
and the cell monolayer within the channel.
3.2.3 Introduction of VEGFR2 Knockdown Co-Culture to Ultra-Low Shear
Stress
The co-culture of fluorescently labelled VEGFR2 knockdown HUVECs and
siRNA control HUVECs was introduced to flow via perfusion of fresh EGM-MV
using a peristaltic pump (MiniPuls3, Gilson) at 14 RPM corresponding to 116
µL/min. The shear stress within the channel was calculated to be 1 dynes/cm2
using an equation for parallel-plate flow chambers derived from the NavierStokes and continuity equations and used frequently in microfluidic studies
(Ahsan and Nerem, 2010). Cells were subjected to a shear stress of 1 dynes/cm2
for 4 h, a shear stress shown to produce adequate alignment and elongation in
ECs lining the microfluidic channel. Flow of the medium was then reduced to 4
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RPM on the peristaltic pump for 6 h, corresponding to a flow rate of 33 µL/min
and resulting in shear stress of 0.29 dynes/cm2.
Following induction of ultra-low shear stress, ECs were fixed via perfusion
of 4% paraformaldehyde (Alfa Aesar, A11313) using programmable syringe
pumps at 3 µL/min at room temperature for 25 min. Cells were then
permeabilized using 0.1% Triton-X 100 (Sigma, T8787) in PBS delivered at 3
µL/min for 15 min, after which the solution was left stationary for 15 min and
washed with PBS at 3 µL/min for 15 min. Blocking was performed by delivery of
5% donkey serum at 3 µL/min for 15 min before blocking solution was left
stationary for 1.5-2 hr. Non-fluorescent HUVECs cultured within the microfluidic
channel were then immunostained for endothelial cell-cell junctions by delivery of
rabbit monoclonal anti-human VE-Cadherin primary antibody (1:200, D87F2, Cell
Signalling Technologies) at 3 µL/min for 15 min. The device was then laid flat and
empty 1 mL syringes were attached to the inlet and outlet tubing of both
channels, ensuring tubing was at equal heights, to reduce residual flow within the
channel. The device was stored in static conditions overnight at 4ºC. The next
day, HUVECs were washed by infusion of PBS at 3 µL/min for 30 min. VECadherin cell-cell junctions visualized using Alexa Fluor-546 conjugated donkey
anti-rabbit IgG (1:400, A10040, Life Technologies) delivered at 3 µL/min for 15
min. The secondary antibody was left static at room temperature for 2 hr, and
was then washed by delivery of PBS at 3 µL/min for 30 min. The F-actin
cytoskeleton was visualized using Alexa Fluor-488 conjugated phalloidin (1:40,
A12379, Invitrogen) delivered at 3 µL/min for 15 min, followed by a static phase
for 30 min and a washing step with PBS delivered at 3 µL/min for 30 min. The
nuclei of both non-fluorescent and fluorescently labelled HUVECs were
visualized using DAPI (1000 nM, D9542, Sigma).
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3.2.4 Confocal Microscopy and Analysis of Pillar Formation in HUVECs
with and without Reduced VEGFR2 Expression
Endothelial cells lining the microfluidic channels were imaged using a
Nikon A1R Confocal Laser Scanning System with a 40x oil-immersion objective
and 405 nm, 488 nm, and 561 nm lasers. Regions of interest imaged using the
Resonance scanning system were taken using up to 250, 0.25 µm-thick z-slices
at a pixel resolution of 300 nm, while those imaged using the Galvano scanning
system were taken using up to 150, 0.25 µm-thick z-slices with a pixel resolution
of 300 nm. Z-slices were then reconstructed into 3D volume images, as well as
maximum intensity planar projections and orthogonal projections using NIS
Elements Software (Nikon).
Aspect ratio among RFP- and GFP-HUVECs was quantified using
maximum planar projections of 14-20 regions of interest generated from z-slices
of the same regions. Individual cells were outlined in ImageJ (NIH) and, using the
“Centroid” and “Fit ellipse” tools, the major axis and minor axis through the
centroid of the cell area were measured and divided to generate the aspect ratio.
Pillar frequency among RFP- and GFP-expressing ECs was quantified using 3D
volume images of dimensions 320 µm x 320 µm x 60 µm (XYZ) from 14-20
regions of interest reconstructed using z-slices of those same regions. The
frequency of pillars among VEGFR2 knockdown and control cells was
determined first by outlining a pillar-competent zone, defined as a 40 µm x 40 µm
(XZ) zone along the bottom surface and side wall of the channel. Second, the
number of cells participating in a pillar was expressed relative to the total cell
number within that zone.
3.2.5 Statistics
Statistical analysis of pillar frequency was performed using Prism 8
(Graphpad Software). The data set was tested for normality using D’Agostino
and Pearson omnibus normality test. Normally distributed data is presented as
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mean ± SEM, and non-normally distributed data is presented as median and
IQR. Comparisons among VEGFR2 knockdown and control cells were made
using a t-test. Statistical significance was set at p<0.05.

3.3 Results
3.3.1 Endothelial Cells Lining a Rectangular Microfluidic Channel are
Capable of Pillar Formation
Current research surrounding the biochemical and biomechanical
regulation of intussusceptive angiogenesis remains elusive. However, some have
suggested a role for VEGFR2 signalling due to its vital function in both sprouting
angiogenesis and shear stress sensing (Gianni-Barrera et al., 2013; GianniBarrera et al., 2018). To explore the relationship between VEGFR2 and EC
transluminal pillar formation, we utilized the protocol developed in Chapter 2 for
the creation of a 3D in vitro microvessel model. To successfully generate a 3D
microfluidic channel lined with a co-culture of RFP- and GFP-HUVECs
transfected with siRNA designed to knockdown VEGFR2 or control siRNA, we
designed and fabricated microchannels 300 µm in height, 1000 µm in width, and
1 cm in length. Notably, these channels had a larger volume to surface area ratio
to increase the viability of transfected HUVECs (Sfriso et al., 2018). We lined the
channel with non-transfected ECs to ensure this new channel design was
capable of culturing a healthy EC monolayer, utilizing immunostaining techniques
to visualize the F-actin cytoskeleton, VE-Cadherin intercellular junctions, and
nuclei via confocal microscopy. Importantly, maximum intensity and orthogonal
projections of ECs lining the channel generated a complete, continuous
monolayer along the surfaces of the channel, as indicated by endothelial cell-cell
junctions outlined by VE-Cadherin staining (Figure 3.1 A-B).
Interestingly, despite the 300 µm height of the microchannel used in this
study, we observed EC transluminal pillar formation throughout the channel.
Microfluidic devices used in this study were constructed in such a way as to
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Figure 3.1 A 3D in vitro microvessel lined with a healthy endothelial cell
monolayer.
A. Confocal planar projection of HUVECs lining the bottom surface of the
microfluidic channel immunostained for VE-Cadherin (red) and stained for F-actin
(green) (150 z-slices, 0.25 µm step-size) showing a healthy EC monolayer. B-C.
Orthogonal projections of HUVECs lining the bottom surface and side wall of the
microfluidic channel immunostained for VE-Cadherin (red) and stained for F-actin
(green) showing a healthy EC monolayer (B) and the formation of endothelial cell
pillars (arrows) within the microfluidic channel (C).

78

79

generate “shoulders”. These “shoulders” were intentionally created by subtle
over-curing of the PDMS-coated glass-bottom dish. This caused a shift in the
PDMS side wall at the site of adhesion to the glass-bottom dish, generating a
geometry wherein pillar formation was possible due to the existence of a
shoulder with a height of 30-40 µm. Under ultra-low shear stress conditions
alone, a proportion of ECs situated close to the side wall of the channel revealed
a projection spanning across the channel lumen identified as a pillar (Figure 3.1
C). Moreover, these pillars also varied in appearance, with some existing as thin
filopodial projections crossing the lumen, while other appeared to include nuclei
within the structure of the pillar itself.
Reconstruction of the 3D volume image occurred by merging 150 z-slices
(0.25 µm step-size), overlapping each image in the X, Y, and Z planes to create
an image that could be reoriented to view the microfluidic channel at any
angle. This 3D image showed a confluent EC monolayer along both the bottom
surface and sidewall of the microfluidic channel as evidenced by nuclei and VECadherin junctions. Close examination of the 3D volume image of an endothelialbased protrusion across the channel lumen provided evidence for the existence
of an EC transluminal pillar within this microfluidic model (Figure 3.2). Notably,
the EC monolayer was continuous on the channel wall behind the pillar and on
the bottom surface surrounding the pillar when looking at the volume image from
various angles. The pillar itself also remained consistent when viewed from
various angles (see Online video 4.2 in Appendix A). It is also important to
observe the definitive presence of multiple cellular organelles within 3Dreconstructed pillars, including VE-Cadherin-positive vesicles/junctions and
nuclei. Taken together, the high-resolution imaging technique demonstrated that
this pillar is not simply a visual overlay artifact, but a natural extension of the
endothelial

cell

body

bridging

the

adjacent

walls

of

microchannel.
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Figure 3.2 Controlled endothelial cell transluminal pillar formation in a 3D
microvessel model.
A 3D volume image reconstructed from 150 confocal z-slices (0.25 µm) of
HUVECs lining the bottom surface and side wall of a microfluidic channel
immunostained for VE-Cadherin (red) and stained for F-actin showing an EC
transluminal pillar (arrow) extending from the bottom surface and connected to
an EC on the side wall of the channel (see Online Video 4.2 in Appendix A).
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3.3.2 Reduced VEGFR2 Expression Results in Less Elongated Endothelial
Cells
Following the generation of our 3D model capable of controlled EC pillar
formation, we sought to directly examine the role of VEGFR2 expression, and
consequently activity, in pillar formation. To do this, we created a co-culture of
RFP- and GFP-expressing HUVECs differentially transfected with either
VEGFR2 siRNA or control siRNA within the microchannel. Cells were seeded at
a 2:3 knockdown to control cell ratio. Furthermore, cells transfected with
VEGFR2 siRNA displayed a 88±5% knockdown efficiency (Figure 3.3 A). Under
ultra-low shear stress conditions, cells transfected with control siRNA showed an
aspect ratio of 2.7. However, transfection with VEGFR2 siRNA resulted in a 21%
decrease in aspect ratio, suggesting reduction of VEGFR2 activity alone lead to
cytoskeletal reorganization and rounding of ECs (p<0.0001, Figure 3.3 B).
3.3.3 Pillar Predisposition in Endothelial Cells with Reduced VEGFR2
Expression
As was the case with non-transfected ECs, pillars were identified as
endothelial-based projections crossing the lumen of the channel, connecting with
a cell on the adjacent wall (Figure 3.4 A-C). Under ultra-low flow, HUVECs
transfected with control siRNA acted as pillar-forming cells, forming the
endothelial-based protrusion, only 0.4% of the time. Remarkably, cells with
reduced VEGFR2 expression showed a 12.5-fold increase in pillar formation
under identical ultra-low shear stress conditions (p=0.0008, Figure 3.4 D).
However, while the majority of pillar-forming cells were cells with reduced
VEGFR2 expression, the pillar formed connected to a cell on the side wall of the
channel that had high VEGFR2 expression.
The finding of increased pillar formation in cells with reduced VEGFR2
expression suggests the downregulation of VEGFR2 signalling could be essential
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Figure 3.3 Endothelial cells with reduced VEGFR2 expression are less
elongated in the direction of flow.
A. Graph showing VEGFR2 abundance measured by qPCR in HUVECs
transfected with control siRNA and HUVECs transfected with siRNA designed to
knockdown VEGFR2 (n=4 samples, p=0.0016). B. Plot from individual cell
quantification showing a decrease in aspect ratio of HUVECs transfected with
VEGFR siRNA (n=4 microfluidic devices, n=395 siCNTRL endothelial cells,
n=379 siVEGFR2 endothelial cells, p<0.0001).
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Figure 3.4 3D co-culture of endothelial cells transfected with control siRNA
or VEGFR2 siRNA reveals an increase in pillar formation among cells with
reduced VEGFR2 expression.
A-C. Confocal 3D volume images reconstructed using 150 z-slices (0.25 µm
step-size) of the corner of a microfluidic channel lined with a co-culture of RFPand GFP-HUVECs transfected with control siRNA or siRNA designed to
knockdown VEGFR2 showing transluminal pillars (arrows) formed by HUVECs
with reduced VEGFR2 expression (A-B, red, and C, green). D. Quantitative data
of EC transluminal pillar frequency, determined by the number of control or
VEGFR2 cells contributing to a pillar divided by the total number of cells within a
pillar-competent zone, showing an increase in pillar formation in cells with
reduced VEGFR2 expression (40 µm x 40 µm, XZ) (n=4 microfluidic devices,
p=0.0008).
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in the progression of intussusceptive angiogenesis via EC transluminal pillar
formation.

3.4 Discussion
Recent research from our lab has shown that regeneration of damaged
microvasculature following ischemic injury in the skeletal muscle relies heavily on
intussusceptive angiogenesis. The biochemical and biomechanical regulation of
intussusceptive angiogenesis is poorly understood. I have shown, using a novel
model of pillar formation that, in contrast to sprouting angiogenesis, pillar
formation is driven by ECs with low VEGFR2.
Studies performed in mouse skeletal muscles have shown an increase in
pillar formation upon delivery of exogenous VEGF, suggesting a potential role for
VEGFR2 signalling within this process of blood vessel growth (Gianni-Barrera et
al., 2018). However, no direct evidence has been reported for the causal
relationship between VEGFR2 and intussusceptive angiogenesis. In this study,
we utilized a novel 3D microvessel model to induce controlled endothelial pillar
formation, a critical step of intussusception. Co-culture of GFP- and RFPHUVECs differentially transfected with VEGFR2 or control siRNA within the
microfluidic channel revealed a 12.5-fold increase in pillar formation in cells with
reduced VEGFR2 expression. This suggests the absence of VEGFR2 signalling
is permissive to EC transluminal pillar formation in intussusceptive angiogenesis.
This would appear to be in contrast with the aforementioned study showing an
increase in intussusceptive angiogenesis in response to VEGF. However, there
may be differences between newly formed blood vessels, as in the current study,
and pre-existing blood vessels.
The microfluidic channel model used in this study was designed to be
rectangular in geometry with the dimensions 300 µm x 1000 µm x 1 cm (h, w, l).
Compared to our microfluidic channel designed to be square in nature discussed
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in Chapter 2, this channel shows less of a resemblance to the normal physiology
of the microvasculature being modelled. Despite this, the microfluidic model
maintains its 3D design, which is essential to creating an in vitro microvessel
model capable of controlled pillar formation. The design of the microfluidic
channel, while seemingly less reflective of blood vessel geometry, was generated
in a way that made co-culture of ECs differentially labelled with either VEGFR2 or
control siRNA possible. The width to height ratio allowed for the optimization of
the viability of cells within the channel, which were less resilient considering the
numerous interventions (Sfriso et al., 2018). The rectangular shape therefore
allowed for an increase in the volume to surface area ratio within the channel,
favouring nutrient delivery to individual cells within the monolayer. Our
microfluidic model featuring a co-culture of RFP- and GFP-HUVECs differentially
labelled with either VEGFR2 siRNA or control siRNA presents the first 3D ex vivo
assessment of VEGFR2 signalling in pillar formation. This unique approach
allowed for direct control of VEGFR2 expression in a subset of ECs within a
given population, with the ability to track the specific cell type in pillar formation
and without confounding factors presented in vivo.
The finding of increased pillar formation in cells with reduced VEGFR2
expression reveals important information on the involvement of VEGFR2 in pillar
formation. This receptor plays a major role in the more well-studied type of
angiogenesis, sprouting angiogenesis–induction of the signalling cascade that
ultimately triggers ECs lining a blood vessel lumen to migrate into the
surrounding tissue and lumenize is dependent on activation of VEGFR2 by its
ligand VEGF-A (Ribatti and Crivellato, 2012). Moreover, this receptor also
participates in a complex with VE-Cadherin and PECAM-1 that is essential for
endothelial cells’ ability to sense and respond to changes in flow (Baeyens et al.,
2016a). Given the importance of shear stress in pillar formation previously
discussed and what is currently known about sprouting angiogenesis in the
microvasculature, it is tempting to look to VEGFR2 as a regulator of
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intussusceptive angiogenesis as well. To that end, studies using the mouse
vasculature have suggested that increased doses of VEGF, and subsequently
increased VEGFR2 activation, leads to pillar formation (Gianna-Barrera et al.,
2013; Groppa et al., 2018). However, it is important to note that these studies
observed dilation of the vessels as a direct result of VEGF delivery, while no
measure of VEGFR2 activation was assessed on an individual cell basis.
Moreover, recent research in our lab using a mouse model of ischemic injury
within the skeletal muscle found instead that inhibition of VEGFR2 resulted in
accentuated EC pillar formation within the early regenerating microvasculature
(Arpino, 2017b). The finding of increased pillar formation among cells with
reduced VEGFR2 activity therefore directly supports a role for VEGFR2 in
inhibiting pillar formation. Taken together with the impact of shear stress
elaborated in Chapter 2, we stipulate that cells with a reduced VEGFR2
signalling capacity are predisposed to form transluminal pillars, a process which
is then encouraged by introduction of ultra-low shear stress.
In summary, the microfluidic model developed herein enables direct study
of the role of VEGFR2 in endothelial pillar formation. From this, we discovered
that ECs with a lower capacity for activating VEGFR2 were primed to participate
in pillar formation under ultra-low flow conditions. These findings further
characterize the biomechanical and biochemical cascades of intussusceptive
angiogenesis, suggesting reconsideration of current therapeutic angiogenesis
techniques used to treat patients with peripheral vascular disease.
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CHAPTER 4:
GENERAL DISCUSSION AND CONCLUSIONS
The findings presented in this thesis uncover new insights into the
biochemical and biomechanical regulation of intussusceptive angiogenesis via
endothelial cell (EC) pillar formation. In this study, I present the first in vitro
method for the study of transluminal pillar formation. I developed the first 3D ex
vivo microvessel model created using polydimethylsiloxane (PDMS) microfluidics
capable of controlled recreation of an EC transluminal pillar. Using this model, I
established several new insights into pillar formation. First, I discovered a
permissive role for ultra-low shear stress in pillar formation, reporting an 8.8-fold
increase in pillar formation under ultra-low shear stress compared to physiologic
shear stress conditions. Second, I discovered the potential participation of
primary cilia in the mechanical regulation of transluminal pillar formation,
reporting an increase in ADP-ribosylation factor-like protein 13b (ARL13b)
density under ultra-low shear stress. Remarkably, primary cilia were also
observed within the pillar structure. Third, I utilized the 3D microvessel model
developed herein to directly investigate the role of vascular endothelial growth
factor receptor 2 (VEGFR2) activation in pillar formation. Under ultra-low shear
stress, I reported a 22% decrease in phosphorylated VEGFR2 (pVEGFR2)
abundance, indicating a decrease in VEGFR2 activation. Notably, I also
observed a 12.5-fold increase in pillar formation among cells with decreased
VEGFR2 expression. Based on the findings herein, I propose a permissive role
for ultra-low shear stress as a biomechanical regulator of pillar formation.
Biochemical regulation of pillar formation is then potentially regulated by primary
cilia and, in parallel, occurs in cells with a lower capacity for VEGFR2 activation.
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4.1 Development of a Novel 3D Microvessel Model using Microfluidics
The methodological approach developed in this study to characterize the
biomechanical and biochemical regulation of EC pillar formation was
accomplished using microfluidics. I was able to create the first ex vivo 3D
microvessel model enabling controlled pillar formation, utilizing the ability to
manipulate flow that is inherent to microfluidics. Microfluidics is a recent
development within the field of bioengineering that focuses on the use of
channels microns in size to study fluid flow. This method of study has many
advantages compared to systems such as parallel flow plates, including a
customizable channel design in terms of both the network of microchannels and
channel geometry, and the ability to control and manipulate the velocity of fluid
flow within the channel. Therefore, in the context of cellular models, this
approach provides a unique opportunity to study vascular biology, specifically EC
response to shear stress.
Endothelial cell microfluidic models have been used extensively to study:
1) EC permeability (Akbari et al., 2018), 2) EC migration (Shih et al., 2019), 3)
the function of the blood-brain barrier (Ahn et al., 2020; Park et al., 2019), 4)
tumor angiogenesis (Amann et al., 2017), and 5) wound healing and hematologic
diseases (Lin et al., 2019; Tsai et al., 2012), among others. The large variability
in the application contexts of microfluidic devices, consequently, leads to a wide
variety of microfluidic channel designs. However, most microfluidic studies utilize
a rectangularly shaped channel or a channel with multiple branching points,
choosing to render the height of the channel similar to blood vessel geometry,
but not the width (Kong et al., 2016; Myers et al., 2012). These design features
help to compensate for the pressure created within the channel by high flow
rates. The model developed in Chapter 2 of this study is therefore unique in that
the height and width are equal, each being 100 µm in size, and create a
microvessel model more reflective of in vivo blood vessel physiology. The
microfluidic channel design in Chapter 3 was similar to others in the literature,

94

with a height of 300 µm and a width of 1000 µm. In this case, the microfluidic
design was used to increase the viability of cells already less resilient to cell
culture due to multiple interventions, including ultra-low flow, siRNA challenge
and, particularly VEGFR2 knockdown (Sfriso et al., 2018).
Moreover, the 3D nature of the microfluidic channel was strategically
used to recreate an environment conducive for pillar formation, wherein cells
were lining all four walls and were therefore capable of bridging between two
adjacent channel walls. Interestingly, within a literature search of endothelialized
microfluidic models, few intentionally aim to develop a similar 3D microvascular
model, while most focus on cells lining the bottom surface of the channel (Maoz,
et al., 2018). The microfluidic microvessel model developed in this study
therefore advances the field by rationally utilizing the 3D nature of microchannels
to create an environment conducive to pillar formation for the first time ex vivo.

4.2 Ultra-Low Flow is Permissive to Transluminal Pillar Formation
Utilizing the full circumferential lining of a microfluidic channel with ECs, I
characterized both EC morphology and pillar formation under ultra-low shear
stress. First, I discovered changes in the shape, alignment, and actin cytoskeletal
organization of cells under ultra-low shear stress. Capillaries experience a shear
stress magnitude of 10-20 dyn/cm2 in vivo (Aird, 2005). Endothelial cells under
these conditions have been well-studied and shown to increase their alignment in
the direction of flow, becoming elongated in shape (Tzima et al., 2005).
Moreover, the actin cytoskeleton under high shear stress is organized into a high
abundance of F-actin stress fibres, contractile bundles of actin filaments that use
focal adhesions to anchor the cytoskeleton to the extracellular matrix (Tojkander
et al., 2012). Under ultra-low shear stress, I identified an overall decrease in
cellular alignment, showing cells more randomly oriented to the direction of flow,
and a decrease in cellular elongation, associated with a more rounded cell
shape. I also observed a decrease in the density of stress fibres, while actin was
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reorganized into cortical bundles along the cell border. Interestingly, EC
responses to low shear stress have largely been studied in the context of
disturbed or turbulent flow, wherein flow patterns are irregular and unpredictable
(Tovar-Lopez et al., 2019). A study by Park et al. (2011) was the only study found
in a literature search to interrogate laminar flow under shear stress conditions <1
dyn/cm2, demonstrating the degree to which ultra-low shear stress is
understudied. This study found that, under ultra-low flow, ECs are randomly
oriented, showing little alignment with the direction of flow with a high incidence
of cortical actin. This directly supports the findings reported herein.
The finding of increased pillar formation under ultra-low shear stress
conditions presents novel information on the biomechanical regulation of
intussusceptive angiogenesis. Specifically, this is the first study to: a) generate
an ex vivo microvessel model capable of reconstitution of EC transluminal pillars
and b) provide direct evidence of the permissive role of ultra-low shear stress in
pillar formation.
Interestingly, research into the role of shear stress in the progression of
intussusceptive

angiogenesis

via

pillar

formation

leads

to

divided

understandings. For many years, researchers had proposed that high shear
stress was critical for the induction of EC transluminal pillar formation (Egginton
et al., 2001; Zhou et al., 1998). A study performed by Ogawa dating back to 1977
gave one of the first descriptions of intussusceptive angiogenesis using electron
microscopy, wherein he postulated that increased blood flow to the rat skeletal
muscle due to exercise lead to an increase in vascularity by intussusception.
However, recent research using computational modeling of angiogenesis in the
chick chorioallantoic membrane (CAM) microvasculature has shown different
findings. It suggested that pillar formation occurs in “dead zones” where the
shear stress levels are below 1 dyn/cm2, and that pillars are constrained by
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surrounding areas of high shear stress (Lee et al., 2011). These computational
models directly support the findings reported herein.
Moreover, the findings within the microfluidic model I developed are in
keeping with findings previously reported by our research group using a mouse
model of peripheral arterial disease (PAD), wherein a high incidence of
transluminal pillars was observed in early regenerating microvessels alongside a
ultra-low shear stress condition (Arpino, 2017b). My discovery of increased pillar
formation under conditions of ultra-low shear stress therefore presents the first
concrete in vitro evidence of the permissive role of low shear stress in pillar
formation. Given this information, my findings raise the prospect to reevaluate
current methods of therapeutic angiogenesis in patients with severe PAD, which
rely heavily on pathways promoting sprouting angiogenesis as opposed to
intussusception (Said et al., 2013).

4.3 Microfluidic Modeling of Pillar Morphogenesis
Intussusceptive angiogenesis is the process of angiogenesis whereby
ECs lining a preexisting blood vessel will protrude into the flowing lumen and
connect to cells on the opposing wall of the vessel, forming an endothelial-based
projection known as a transluminal pillar (Djonov et al., 2000). Multiple pillars will
form down the length of the vessel, which will then expand along the long axis of
the vessel and fuse with neighbouring pillars to split one large vessel into two
smaller vessels (Gianna-Barrera et al., 2013; Mentzer and Konderding, 2014).
Interestingly, in the 3D microvessel model developed in this study, I observed a
spectrum of pillar structures, as well as multiple pillars within the same region of
interest, that parallel the in vivo morphogenesis of pillars described. Frequently, I
identified transluminal pillars with an appearance of slender endothelial-based
projections immuno-positive of F-actin. However, I also observed transluminal
pillars that were wider in nature, appearing to have expanded down the long axis
within the channel. Many of these pillars contained a nucleus within the widened
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base of the pillar structure, but clearly above the plane of the monolayer.
Furthermore, there was one instance of pillar overlap–in this case, two
neighboring pillars had appeared to widen down the axis of the channel and fuse,
overlapping at their bases just above the cell monolayer along the bottom surface
of the channel.
While the exact mechanism of pillar extension is unknown, the variation in
pillar structure reported herein could be considered as an in vitro model for pillar
morphogenesis of different phases/stages. The first phase of initial pillar
formation

would

occur

via

endothelial-based

projections

across

the

channel/lumen that appear slender. The second phase would then involve the
extension of pillar along the long axis of the channel, correlated with the
migration of the nucleus into the pillar. This would then be followed by a
theoretical final phase, wherein neighbouring pillars fuse to create a secondary
lumen. This latter phase might be observed with future developments of
microfluidic designs and culture conditions (such as circulating growth
factors/cytokines, basement membrane-like ECM, mural cell or leukocyte coculture). Taken together, the model developed in this study demonstrates a novel
in vitro methodology to interrogate the occurrence and progression of
intussusceptive angiogenesis, providing new insights into pillar morphogenesis
without potential confounding factors seen in studies performed in vivo.

4.4 Mechanosensing Regulators of Pillar Formation
Transluminal pillar formation, as discussed above, was shown to correlate
directly with changes in the magnitude of shear stress sensed by ECs,
suggesting mechanosensing is crucial for EC pillar morphogenesis. To further
characterize EC transluminal pillar formation, I studied several candidate shear
stress sensors previously reported in the literature to have a specific relevance to
EC functionality (Ando and Yamamoto, 2013). My thesis work described herein
focuses explicitly on the expression and subcellular localization of shear sensors
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including primary cilia and activation of VEGFR2 in ECs circumferentially lining a
microfluidic channel. I further characterize the responses of these sensors to a
pillar-permissive ultra-low shear stress. Under these shear stress conditions, I
observed: 1) an increase in primary cilia via ARL13b, 2) a decrease in pVEGFR2
expression, and 3) an increase in pillar formation in ECs with reduced VEGFR2
expression. Furthermore, both primary cilia and activation of VEGFR2 were
discovered within the pillar structure protruding into the lumen of the channel.
Notably, pVEGFR2 was localized within the middle of the pillar and lateralized to
the upstream side of the pillar, signifying elevated levels of shear stress in this
region. While the increase in primary cilia within ECs under ultra-low flow alludes
to an active role for primary cilia in pillar formation, the decrease in pVEGFR2
and increase in pillar formation in cells with reduced VEGFR2 suggests that the
downregulation of VEGFR2 signalling promotes pillar formation. Taken together,
these findings suggest that particular shear stress sensors have differing roles in
the formation and progression of pillar morphogenesis and outline the potential
for specific signalling pathways important for regulating this process.
Furthermore, the findings outlined above support the notion that
transluminal pillar formation in intussusceptive angiogenesis is encouraged when
ECs adopt a flow-seeking behaviour. Under conditions of ultra-low shear stress,
ECs lining a microvessel may struggle to sense shear stress caused by the
flowing blood. The increase in primary cilia demonstrated in this study would
therefore act as a direct response to the cell’s difficulty to sense flow: by
increasing primary cilia, cells within the monolayer increase the presence of
shear stress sensors on their plasma membranes and magnify the signal
transmitted by these sensors to the cell. In a similar manner, pillar formation
could therefore be considered as a migratory act of flow-seeking. Endothelial
cells lining the vessel wall with a diminished capacity to activate VEGFR2 then
form a bridge across the flowing lumen, migrating towards the centre of the
vessel lumen where shear stress would be higher and allowing the cell to sense
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the magnitude of shear stress more easily. This model of pillar formation is
supported by the discovery of pVEGFR2 localized and lateralized to the middle,
upstream side of EC transluminal pillars in this study, suggesting elevated shear
stress within the lumen of the channel. Interestingly, a computational CAM model
of EC transluminal pillars by Filipovic et al. (2009) have demonstrated elevated
shear stress in the mid-section and on the upstream side of EC pillars, further
supporting this flow-seeking model of pillar formation.
Finally, the finding of increased pillar formation under ultra-low shear
stress in ECs with reduced VEGFR2 expression is interesting. Sprouting
angiogenesis is the most commonly understood and well-studied form of
angiogenesis and knowledge of the regulatory mechanisms of this process have
been heavily relied upon to inform strategies of therapeutic angiogenesis in
patients with PAD (Gupta et al., 2009; Cooke and Losordo, 2015). As such, it is
tempting to consider intussusceptive angiogenesis in relation to sprouting,
specifically in terms of biochemical regulation. Given the crucial importance of
VEGFR2 signalling in sprouting (Ribatti and Crivellato, 2012), one could draw the
conclusion that VEGFR2 signalling may also play an important role in
intussusception. Studies performed in the vasculature of the mouse skeletal
muscle have even suggested this is the case (Gianna-Barrera et al., 2018;
Groppa et al., 2018). However, the results in my work suggest instead that the
suppression of VEGFR2 signalling is permissive to EC pillar formation. Moreover,
previous research performed by our research group in a mouse model of
ischemic injury similarly demonstrated that blocking VEGFR2 activation led to an
increase in pillar formation in vivo, supporting my findings (Arpino, 2017b).
Therefore, I propose that VEGFR2 activity plays a role instead in the decision of
endothelial cell to undergo intussusceptive pillar formation. Under high shear
stress conditions, VEGFR2 would be activated in a ligand-independent manner,
contributing to EC elongation and preventing pillar formation from occurring.
However, under ultra-low shear stress conditions, the ligand-independent
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activation of VEGFR2 decreases, enabling more individualized cells to undergo
pillar formation. This hypothetical scenario is supported by my finding that siRNAmediated VEGFR2 downregulation enhances the pillar formation of individual
ECs under ultra-low shear condition.
In summary, based on the findings in my thesis study, I propose a model
of EC transluminal pillar formation wherein ECs adopt a flow-seeking behaviour.
Specifically, ultra-low shear stress conditions result in low shear inputs from
blood flow and create a need for ECs to become more sensitive to shear. This
results in an increase in primary cilia on the plasma membrane of cells within the
monolayer, magnifying shear stress signalling. Endothelial cells with a reduced
capacity for activation of VEGFR2 are in parallel primed to protrude into the
lumen of the vessel where shear stress is elevated and information concerning
the magnitude and direction of shear can be more easily sensed by the cell and,
possibly, communicated to the EC monolayer.

4.5 Future Directions
The findings of 1) pillar morphogenesis in the progression of
intussusceptive angiogenesis and 2) the functional roles of shear stress sensors
in transluminal pillar formation require further investigation, as these phenomena
are vital to our understanding of intussusceptive angiogenesis and will need to be
considered when developing novel therapies for PAD.
To further study pillar morphogenesis, it is important to consider the
progression of pillar formation and extension over time. While my findings have
suggested that pillar formation occurs in a phased manner whereby a slender
pillar will widen and fuse with neighbouring pillars, the exact mechanism of pillar
formation remains unknown. Specifically, aside from a protrusive event
hypothesis, it is equally possible that formation of a pillar occurs when a cell
previously lining the wall of the vessel delaminates from the established
basement membrane and moves into the lumen, connecting to a cell on the
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adjacent or opposing vessel wall. To interrogate this further, the model I have
developed in this study could be used to generate a 3D live cell imaging
experiment with fluorescently labelled cells using confocal microscopy. Real time
imaging of cells subjected to ultra-low shear would allow the investigation of
pillars as they form.
It is also important to further investigate the functional roles of shear stress
sensors in pillar formation. My findings have revealed important information
concerning primary cilia and VEGFR2, two prominent endothelial shear stress
sensors, but there are many others that could contribute to pillar formation, as
well as the decision to undergo intussusception instead of sprouting.
Immunostaining of select shear stress sensors in my microfluidic design and in
microvessels undergoing intussusception, such as GPR68, Notch1, Piezo1, b1
integrin, or Alk1, could quickly and efficiently uncover more precise signalling
cascade(s) involved in the regulation of intussusceptive angiogenesis (Ando and
Yamamoto, 2013). Moreover, loss-of-function experiments on select shear
sensors, such as RNAi- or CRISPR/Cas9-based gene inactivation are warranted
to establish their functions in pillariogenesis.
The landscape of shear stress sensors in pillar formation could also be
further explored via RNA sequencing. While it may be technically difficult to
remove cells from the channel surface without negative consequences, genomewide sequencing of these cells could reveal important changes in gene regulation
in ECs subjected to ultra-low shear stress. Moreover, because of the 3D nature
of the microfluidic model developed, these cells would reflect ECs lining
microvessels in vivo more closely and may present new information regarding
cell-cell communication within a 3D environment.

4.6 Conclusions
In conclusion, I have developed the first 3D ex vivo microvessel model
using microfluidics capable of controlled EC transluminal pillar formation. This
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model was then used to interrogate the biomechanical and biochemical
regulation of pillar formation. I discovered that, under ultra-low shear stress
conditions, ECs had increased primary cilia. I also proved that ECs with a low
capacity for VEGFR2 activation are primed to form an EC transluminal pillar
under ultra-low shear conditions. These findings uncover vital information on the
initiation and progression of intussusceptive angiogenesis in relevance with
ischemic skeletal muscle that could inform the development of therapeutic
strategies for PAD.

4.7 References
Ahn, S.I., Sei, Y.J., Park, H.J., Kim, J., Ryu, Y., Choi, J.J., Sung, H.J.,
MacDonald, T.J., Levey, A.I., and Kim, Y. (2020). Microengineered human
blood-brain barrier platform for understanding nanoparticle transport
mechanisms. Nat Commun 11, 175.
Aird, W.C. (2005). Spatial and temporal dynamics of the endothelium. J Thromb
Haemost 3, 1392-1406.
Akbari, E., Spychalski, G.B, Rangharajan, K.K., Prakash, S., and Song, J.W.
(2018). Flow dynamics control endothelial permeability in a microfluidic
vessel bifurcation model. Lab Chip 18, 1084-1093.
Amann, A., Zwierzina, M., Koeck, S., Gamerith, G., Pechriggl, E., Huber, J.M.,
Lorenz, E., Kelm, J.M., Hilbe, W., Zwierzina, H., et al. (2017).
Development of a 3D angiogenesis model to study tumour – endothelial
cell interactions and the effects of anti-angiogeneic drugs. Sci Rep 7,
2963.
Ando, J., and Yamamoto, K. 2013. Flow detection and calcium signalling in
vascular endothelial cells. Cardiovasc Res 99, 260-268.
Arpino, G.M. (2017b). Angiogenesis And Neo-Microcirculatory Function In
Diseased Tissue Revealed By Intravital Microscopy. Electronic Thesis and
Dissertation Repository, 4731.
Cooke, J.P., and Losordo, D.W. (2015). Modulating the vascular response to limb

103

ischemia: angiogenic and cell therapies. Circ Res 116, 1561-1578.
Djonov, V., Schmid, M., Tschanz, S.A., and Burri, P.H. (2000). Intussusceptive
angiogenesis: its role in embryonic vascular network formation. Circ Res
86, 286-292.
Egginton, S., Zhou, A.L., Brown, M.D., and Hudlická, O. (2001). Unorthodox
angiogenesis in skeletal muscle. Cardiovasc Res 49, 634-646.
Filipovic, N., Tsuda, A., Lee, G.S., Miele, L.F., Lin, M., Konerding, M.A., and
Mentzer, S.J. (2009). Computational flow dynamics in a geometric model
of intussusceptive angiogenesis. Microvasc Res 78, 286-293.
Gianna-Barrera, R., Butschkau, A., Uccelli A., Certelli, A., Valente, P.,
Bartolomeo, M., Groppa, E., Burger, M.G., Hlushchuk, R., Heberer, M. et
al. (2018). PDGF-BB regulates splitting angiogenesis in skeletal muscle by
limiting VEGF-induced endothelial proliferation. Angiogenesis 21, 883900.
Gianna-Barrera, R., Trani, M., Fontanellaz, C., Heberer, M., Djonov, V.,
Hlushchuk, R., and Banfi, A. (2013). VEGF over-expression in skeletal
muscle induces angiogenesis by intussusception rather than sprouting.
Angiogenesis 16, 123-136.
Groppa, E., Brkic, S., Uccelli, A., Wirth, G., Korpisalo-Pirinen, P., Filippova, M.,
Dasen, B., Sacchi, V., Muraro, M.G., Trani, M. et al. (2018).
EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by
VEGF. EMBO Rep 19, e45054.
Gupta, R., Tongers, J., and Losordo, D.W. (2009). Human studies of angiogenic
gene therapy. Circ Res 105, 724-736.
Kong, J., Luo, Y., Jin, D., An, F., Zhang, W., Liu, L., Li, J., Fang, S., Li, X., Yang,
X., et al. (2016). A novel microfluidic model can mimic organ-specific
metastasis of circulation tumor cells. Oncotarget 7, 78421-78432.
Lee, G.S., Filipovic N., Lin, M., Gibney, B.C., Simpson, D.C., Konerding, M.A.,
Tsuda, A., and Mentzer, S. (2011). Intravascular pillars and pruning in the

104

extraembryonic vessels of chick embryos. Dev Dyn 240, 1335-1343.
Lin, J.Y., Lo, K.Y., and Sun, Y.S. (2019). A microfluidics-based wound-healing
assay for studying the effects of shear stresses, wound widths, and
chemicals on the wound-healing process. Sci Rep 9, 20016.
Maoz, B.M., Herland, A., FitzGerald, E.A., Grevesse, T., Vidoudez, C., Pacheco,
A.R., Sheehy, S.P., Park, T.E., Dauth, S., Mannix, R., et al. (2018). A
linked organ-on-a-chip model of the human neurovascular unit reveals the
metabolic coupling of endothelial and neuronal cells. Nat Biotechnol 36,
865-874.
Mentzer, S.J., and Konerding, M.A. (2014). Intussusceptive angiogenesis:
expansion and remodeling of microvascular networks. Angiogenesis 17,
499-509.
Myers, D.R., Sakurai, Y., Tran, R., Ahn, B., Hardy, E.T., Mannino, R., Kita, A.,
Tsai, M., and Lam, W.A. (2012). Endothelialized microfluidics for studying
microvascular interactions in hematologic diseases. J Vis Exp 64, e3958.
Ogawa, Y. (1977). On the fine structural changes of the microvascular beds in
skeletal muscle. J Yokohama City Univ Ser Sport Sci Med 6, 1-19.
Park, J.Y., White, J.B., Walker, N., Kuo, C.H., Cha, W., Meyerhoff, M.E., and
Takayama, S. (2011). Responses of endothelial cells to extremely slow
flows. Biomicrofluidics 5, 22211.
Park, T.E., Mustafaoglu, N., Herland, A., Hasselkus, R., Mannix, R., FitzGerald,
E.A., Prantil-Baun, R., Watters, A., Henry, O., Benz, M., et al. (2019).
Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier
function and shuttling of drugs and antibodies. Nat Commun 10, 2621.
Ribatti, D., and Crivellato, E. (2012). "Sprouting angiogenesis", a reappraisal.
Dev Biol 372, 157-165.
Said, S.S., Pickering, J.G., and Mequanint, K. (2013). Advances in growth factor
delivery for therapeutic angiogenesis. J Vasc Res 50, 35-51.
Sfriso, R., Zhang, S., Bichsel, C.A., Steck, O., Despont, A., Guenat, O.T., and

105

Rieben, R. (2018). 3D artificial round section micro-vessels to investigate
endothelial cells under physiological flow conditions. Sci Rep 8, 5898.
Shih, H.C., Lee. T.A., Wu, H.M., Ko, P.L., Liao, W.H., and Tung, Y.C. (2019).
Mircofluidic Collective Cell Migration Assay for Study of Endothelial Cell
Proliferation and Migration under Combinations of Oxygen Gradients,
Tensions, and Drug Treatments. Sci Rep 9, 8234.
Tojkander, S., Gateva, G., and Lappalainen, P. (2012). Actin stress fibres—
assembly, dynamics and biological roles. J Cell Sci 125, 1855-1864.
Tovar-Lopez, F., Thurgood, P., Gilliam, C., Nguyen, N., Pirogova, E.,
Khoshmanesh, K., and Baratchi, S. (2019). A Microfluidic System for
Studying the Effects of Disturbed Flow on Endothelial Cells. Front Bioeng
Biotechnol 7, 81.
Tsai, M., Kita, A., Leach, J., Rounsevell, R., Huang J.N., Moake, J., Ware, R.E.,
Fletcher, D.A., and Lam, W.A. (2012). In vitro modeling of the
microvascular occlusion and thrombosis that occur in hematologic
diseases using microfluidic technology. J Clin Invest 122, 408-418.
Tzima, E., Irani-Tehrani, M., Kiosses, W.B., Dejana, E., Schultz, D.A.,
Engelhardt, B., Cao, G., Delisser, H., and Schwartz, M. A. (2005). A
mechanosensory complex that mediates the endothelial cell response to
fluid shear stress. Nature 437, 426-31.
Zhou, A., Egginton, S., Hudlická, O., and Brown, M.D. (1998). Internal division of
capillaries in rat skeletal muscle in response to chronic vasodilator
treatment with alpha1-antagonist prazosin. Cell Tissue Res 293, 292-303.

106

APPENDIX
Appendix A: Legends for Supplemental Video Files
Online Video 4.1: Video rotating along the X-axis of a 3D volume image
reconstructed from 150 confocal z-slices (0.25 µm step-size) showing multiple
endothelial cell transluminal pillars stained for F-actin and nuclei bridging from
the bottom surface to the side wall of a microfluidic channel.
Online Video 4.2: Video rotating along the X-axis of a 3D volume image
reconstructed from 150 confocal z-slices (0.25 µm step-size) showing an
endothelial cell transluminal pillar immunostained for VE-Cadherin and stained
for F-actin bridging from the bottom surface to the side wall of a microfluidic
channel lined with a confluent layer of endothelial cells.
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